DRUG_ID,Drug_Name,Synonyms,Target,Target_Pathway,pubchem_id,molecular_weight,elements,2bonds,3bonds,xlogp,formal_charge,surface_area,complexity,h_bond_donor_count,h_bond_acceptor_count,rotatable_bond_count,heavy_atom_count,atom_stereo_count,defined_atom_stereo_count,undefined_atom_stereo_count,bond_stereo_count,covalent_unit_count,molecular_formula,canonical_smiles,inchi_string,inchi_key,Pt,Br,N,I,O,B,Cl,S,F,P
1,Erlotinib,"Tarceva, RG-1415, CP-358774, OSI-774, Ro-508231, R-1415",EGFR,EGFR signaling,176870,393.4,"'C', 'N', 'H', 'O'",8,1,3.3,0.0,74.7,525.0,1,7,11,29,0,0,0,0,1,C22H23N3O4,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,"InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)",AAKJLRGGTJKAMG-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
3,Rapamycin,"AY-22989, Sirolimus, WY-090217, Torisel, Rapamune",MTORC1,PI3K/MTOR signaling,5384616,184.18,"'C', 'N', 'H'",4,2,1.3,0.0,73.0,296.0,1,3,3,14,0,0,0,0,1,C9H6N5,C1=CC=C(C=C1)N=C(NC#N)[N]C#N,"InChI=1S/C9H6N5/c10-6-12-9(13-7-11)14-8-4-2-1-3-5-8/h1-5H,(H,12,14)",XNRUSHCDWNKUDO-UHFFFAOYSA-N,0,0,1,0,0,0,0,0,0,0
5,Sunitinib,"Sutent, Sunitinib Malate, SU-11248","PDGFR, KIT, VEGFR, FLT3, RET, CSF1R",RTK signaling,5329102,398.5,"'N', 'O', 'H', 'C', 'F'",8,0,2.6,0.0,77.2,636.0,3,4,7,29,0,0,0,1,1,C22H27FN4O2,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,"InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-",WINHZLLDWRZWRT-ATVHPVEESA-N,0,0,1,0,1,0,0,0,1,0
6,PHA-665752,"PHA665752, PHA 665752",MET,RTK signaling,10461815,641.6,"'N', 'O', 'H', 'C', 'Cl', 'S'",13,0,5.0,0.0,111.0,1180.0,2,5,7,43,1,1,0,1,1,C32H34Cl2N4O4S,CC1=C(NC(=C1C(=O)N2CCCC2CN3CCCC3)C)C=C4C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O,"InChI=1S/C32H34Cl2N4O4S/c1-19-29(35-20(2)30(19)32(40)38-14-6-7-21(38)17-37-12-3-4-13-37)16-24-23-15-22(10-11-28(23)36-31(24)39)43(41,42)18-25-26(33)8-5-9-27(25)34/h5,8-11,15-16,21,35H,3-4,6-7,12-14,17-18H2,1-2H3,(H,36,39)/b24-16-/t21-/m1/s1",OYONTEXKYJZFHA-SSHUPFPWSA-N,0,0,1,0,1,0,1,1,0,0
9,MG-132,"LLL cpd, MG 132, MG132","Proteasome, CAPN1",Protein stability and degradation,462382,475.6,"'C', 'N', 'H', 'O'",7,0,4.8,0.0,114.0,644.0,3,5,15,34,3,3,0,0,1,C26H41N3O5,CC(C)CC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCC1=CC=CC=C1,"InChI=1S/C26H41N3O5/c1-17(2)12-21(15-30)27-24(31)22(13-18(3)4)28-25(32)23(14-19(5)6)29-26(33)34-16-20-10-8-7-9-11-20/h7-11,15,17-19,21-23H,12-14,16H2,1-6H3,(H,27,31)(H,28,32)(H,29,33)/t21-,22-,23-/m0/s1",TZYWCYJVHRLUCT-VABKMULXSA-N,0,0,1,0,1,0,0,0,0,0
11,Paclitaxel,"BMS-181339-01, Taxol, Onxol, Paxene, Praxel, Abraxane",Microtubule stabiliser,Mitosis,36314,853.9,"'C', 'N', 'H', 'O'",16,0,2.5,0.0,221.0,1790.0,4,14,14,62,11,11,0,0,1,C47H51NO14,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,"InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1",RCINICONZNJXQF-MZXODVADSA-N,0,0,1,0,1,0,0,0,0,0
17,Cyclopamine,-,SMO,Other,442972,411.6,"'C', 'N', 'H', 'O'",2,0,3.5,0.0,41.5,801.0,2,3,0,30,10,10,0,0,1,C27H41NO2,CC1CC2C(C(C3(O2)CCC4C5CC=C6CC(CCC6(C5CC4=C3C)C)O)C)NC1,"InChI=1S/C27H41NO2/c1-15-11-24-25(28-14-15)17(3)27(30-24)10-8-20-21-6-5-18-12-19(29)7-9-26(18,4)23(21)13-22(20)16(27)2/h5,15,17,19-21,23-25,28-29H,6-14H2,1-4H3/t15-,17+,19-,20-,21-,23-,24+,25-,26-,27-/m0/s1",QASFUMOKHFSJGL-LAFRSMQTSA-N,0,0,1,0,1,0,0,0,0,0
29,AZ628,"AZ-628, AZ 628",BRAF,ERK MAPK signaling,11676786,451.5,"'C', 'N', 'H', 'O'",12,1,4.2,0.0,97.6,845.0,2,5,5,34,0,0,0,0,1,C27H25N5O2,CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(C)(C)C#N)NC3=CC4=C(C=C3)N=CN(C4=O)C,"InChI=1S/C27H25N5O2/c1-17-8-9-21(31-25(33)18-6-5-7-19(12-18)27(2,3)15-28)14-24(17)30-20-10-11-23-22(13-20)26(34)32(4)16-29-23/h5-14,16,30H,1-4H3,(H,31,33)",ZGBGPEDJXCYQPH-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
30,Sorafenib,"Nexavar, 284461-73-0, BAY 43-9006","PDGFR, KIT, VEGFR, RAF",RTK signaling,216239,464.8,"'N', 'O', 'H', 'C', 'Cl', 'F'",11,0,4.1,0.0,92.4,646.0,3,7,5,32,0,0,0,0,1,C21H16ClF3N4O3,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,"InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)",MLDQJTXFUGDVEO-UHFFFAOYSA-N,0,0,1,0,1,0,1,0,1,0
32,Tozasertib,"MK 0457,MK-0457,MK-045, VX-680 VX 680 VX-68","AURKA, AURKB, AURKC, others",Mitosis,5494449,464.6,"'N', 'O', 'H', 'C', 'S'",9,0,3.4,0.0,127.0,650.0,3,8,7,33,0,0,0,0,1,C23H28N8OS,CC1=CC(=NN1)NC2=CC(=NC(=N2)SC3=CC=C(C=C3)NC(=O)C4CC4)N5CCN(CC5)C,"InChI=1S/C23H28N8OS/c1-15-13-20(29-28-15)25-19-14-21(31-11-9-30(2)10-12-31)27-23(26-19)33-18-7-5-17(6-8-18)24-22(32)16-3-4-16/h5-8,13-14,16H,3-4,9-12H2,1-2H3,(H,24,32)(H2,25,26,27,28,29)",GCIKSSRWRFVXBI-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
34,Imatinib,"Gleevec, STI-571","ABL, KIT, PDGFR",RTK signaling,5291,493.6,"'C', 'N', 'H', 'O'",13,0,3.5,0.0,86.3,706.0,2,7,7,37,0,0,0,0,1,C29H31N7O,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,"InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)",KTUFNOKKBVMGRW-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
35,NVP-TAE684,"NVP-TAE 684, TAE684, TAE-684",ALK,RTK signaling,16038120,614.2,"'N', 'O', 'H', 'C', 'Cl', 'S'",11,0,5.7,0.0,111.0,940.0,2,10,9,42,0,0,0,0,1,C30H40ClN7O3S,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,"InChI=1S/C30H40ClN7O3S/c1-21(2)42(39,40)28-8-6-5-7-26(28)33-29-24(31)20-32-30(35-29)34-25-10-9-23(19-27(25)41-4)37-13-11-22(12-14-37)38-17-15-36(3)16-18-38/h5-10,19-22H,11-18H2,1-4H3,(H2,32,33,34,35)",QQWUGDVOUVUTOY-UHFFFAOYSA-N,0,0,1,0,1,0,1,1,0,0
37,Crizotinib,"Xalkori, PF2341066, PF-2341066, PF 2341066","MET, ALK, ROS1",RTK signaling,11626560,450.3,"'N', 'O', 'H', 'C', 'Cl', 'F'",8,0,3.7,0.0,78.0,558.0,2,6,5,30,1,1,0,0,1,C21H22Cl2FN5O,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,"InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1",KTEIFNKAUNYNJU-GFCCVEGCSA-N,0,0,1,0,1,0,1,0,1,0
38,Saracatinib,"AZD0530, AZD-0530, AZ-10353926","ABL, SRC",RTK signaling,10302451,542.0,"'N', 'O', 'H', 'C', 'Cl'",8,0,4.1,0.0,90.4,743.0,1,10,8,38,0,0,0,0,1,C27H32ClN5O5,CN1CCN(CC1)CCOC2=CC3=C(C(=C2)OC4CCOCC4)C(=NC=N3)NC5=C(C=CC6=C5OCO6)Cl,"InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)",OUKYUETWWIPKQR-UHFFFAOYSA-N,0,0,1,0,1,0,1,0,0,0
41,S-Trityl-L-cysteine,"NSC 83265, Tritylcysteine",KIF11,Mitosis,76044,363.5,"'N', 'O', 'H', 'C', 'S'",10,0,2.0,0.0,88.6,392.0,2,4,7,26,1,1,0,0,1,C22H21NO2S,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)SCC(C(=O)O)N,"InChI=1S/C22H21NO2S/c23-20(21(24)25)16-26-22(17-10-4-1-5-11-17,18-12-6-2-7-13-18)19-14-8-3-9-15-19/h1-15,20H,16,23H2,(H,24,25)/t20-/m0/s1",DLMYFMLKORXJPO-FQEVSTJZSA-N,0,0,1,0,1,0,0,1,0,0
45,Z-LLNle-CHO,"Z-L-Norleucine-CHO, Gamma-Secretase Inhibitor 1",gamma-secretase,Other,16760646,475.6,"'C', 'N', 'H', 'O'",7,0,4.9,0.0,114.0,632.0,3,5,16,34,3,2,1,0,1,C26H41N3O5,CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCC1=CC=CC=C1,"InChI=1S/C26H41N3O5/c1-6-7-13-21(16-30)27-24(31)22(14-18(2)3)28-25(32)23(15-19(4)5)29-26(33)34-17-20-11-9-8-10-12-20/h8-12,16,18-19,21-23H,6-7,13-15,17H2,1-5H3,(H,27,31)(H,28,32)(H,29,33)/t21?,22-,23+/m0/s1",RNPDUXVFGTULLP-ATTQYFOMSA-N,0,0,1,0,1,0,0,0,0,0
51,Dasatinib,"BMS-354825-03, BMS-354825, Sprycel","ABL, SRC, Ephrins, PDGFR, KIT",Other,3062316,488.0,"'N', 'O', 'H', 'C', 'Cl', 'S'",9,0,3.6,0.0,135.0,642.0,3,9,7,33,0,0,0,0,1,C22H26ClN7O2S,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,"InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)",ZBNZXTGUTAYRHI-UHFFFAOYSA-N,0,0,1,0,1,0,1,1,0,0
52,GNF-2,KIN001-013,BCR-ABL,ABL signaling,5311510,374.3,"'N', 'O', 'H', 'C', 'F'",10,0,3.8,0.0,90.1,498.0,2,8,5,27,0,0,0,0,1,C18H13F3N4O2,C1=CC(=CC(=C1)C(=O)N)C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F,"InChI=1S/C18H13F3N4O2/c19-18(20,21)27-14-6-4-13(5-7-14)25-16-9-15(23-10-24-16)11-2-1-3-12(8-11)17(22)26/h1-10H,(H2,22,26)(H,23,24,25)",WEVYNIUIFUYDGI-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
53,CGP-60474,"KIN001-019, CGP60474, CGP 60474","CDK1,CDK2,CDK5,CDK7,CDK9, PKC",Cell cycle,644215,355.8,"'N', 'O', 'H', 'C', 'Cl'",9,0,3.8,0.0,83.0,389.0,3,6,7,25,0,0,0,0,1,C18H18ClN5O,C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO,"InChI=1S/C18H18ClN5O/c19-14-3-1-4-15(12-14)23-18-22-9-6-16(24-18)13-5-8-21-17(11-13)20-7-2-10-25/h1,3-6,8-9,11-12,25H,2,7,10H2,(H,20,21)(H,22,23,24)",IYNDTACKOAXKBJ-UHFFFAOYSA-N,0,0,1,0,1,0,1,0,0,0
54,CGP-082996,"CINK4, KIN001-021",CDK4,Cell cycle,24825971,456.6,"'C', 'N', 'H', 'O'",10,0,5.4,0.0,87.0,608.0,4,6,8,34,0,0,0,0,1,C27H32N6O,CCNC1=CC(=NC(=N1)NC2=CC3=C(C=C2)N(C=C3)CC4=CC=CC=C4)NC5CCC(CC5)O,"InChI=1S/C27H32N6O/c1-2-28-25-17-26(29-21-8-11-23(34)12-9-21)32-27(31-25)30-22-10-13-24-20(16-22)14-15-33(24)18-19-6-4-3-5-7-19/h3-7,10,13-17,21,23,34H,2,8-9,11-12,18H2,1H3,(H3,28,29,30,31,32)",YVXCDLCJCIDFHE-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
55,A-770041,KIN001-111,"LCK, FYN","Other, kinases",9549184,621.7,"'C', 'N', 'H', 'O'",13,0,3.3,0.0,136.0,1070.0,2,8,6,46,0,0,0,0,1,C34H39N9O3,CC(=O)N1CCN(CC1)C2CCC(CC2)N3C4=NC=NC(=C4C(=N3)C5=CC(=C(C=C5)NC(=O)C6=CC7=CC=CC=C7N6C)OC)N,"InChI=1S/C34H39N9O3/c1-21(44)41-14-16-42(17-15-41)24-9-11-25(12-10-24)43-33-30(32(35)36-20-37-33)31(39-43)23-8-13-26(29(19-23)46-3)38-34(45)28-18-22-6-4-5-7-27(22)40(28)2/h4-8,13,18-20,24-25H,9-12,14-17H2,1-3H3,(H,38,45)(H2,35,36,37)",ZMNWFTYYYCSSTF-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
56,WH-4-023,KIN001-112,"SRC, LCK","Other, kinases",11844351,568.7,"'C', 'N', 'H', 'O'",13,0,5.9,0.0,92.3,826.0,1,9,9,42,0,0,0,0,1,C32H36N6O4,CC1=C(C(=CC=C1)C)OC(=O)N(C2=C(C=C(C=C2)OC)OC)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5CCN(CC5)C,"InChI=1S/C32H36N6O4/c1-22-7-6-8-23(2)30(22)42-32(39)38(27-14-13-26(40-4)21-28(27)41-5)29-15-16-33-31(35-29)34-24-9-11-25(12-10-24)37-19-17-36(3)18-20-37/h6-16,21H,17-20H2,1-5H3,(H,33,34,35)",NBTNHSGBRGTFJS-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
59,WZ-1-84,KIN001-123,BMX,"Other, kinases",49821040,448.5,"'C', 'N', 'H', 'O'",10,0,2.8,0.0,119.0,698.0,3,7,7,33,1,0,1,0,1,C23H28N8O2,CCC(=O)N(C)C1=CC=C(C=C1)NC2=NC3=C(C(=N2)NC4CCCN(C4)C(=O)C=C)NC=N3,"InChI=1S/C23H28N8O2/c1-4-18(32)30(3)17-10-8-15(9-11-17)27-23-28-21-20(24-14-25-21)22(29-23)26-16-7-6-12-31(13-16)19(33)5-2/h5,8-11,14,16H,2,4,6-7,12-13H2,1,3H3,(H3,24,25,26,27,28,29)",OTPQDXLFXQGSHS-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
60,BI-2536,-,"PLK1, PLK2, PLK3",Cell cycle,11364421,521.7,"'C', 'N', 'H', 'O'",8,0,3.7,0.0,103.0,816.0,2,8,7,38,1,1,0,0,1,C28H39N7O3,CCC1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C,"InChI=1S/C28H39N7O3/c1-5-22-27(37)34(3)23-17-29-28(32-25(23)35(22)20-8-6-7-9-20)31-21-11-10-18(16-24(21)38-4)26(36)30-19-12-14-33(2)15-13-19/h10-11,16-17,19-20,22H,5-9,12-15H2,1-4H3,(H,30,36)(H,29,31,32)/t22-/m1/s1",XQVVPGYIWAGRNI-JOCHJYFZSA-N,0,0,1,0,1,0,0,0,0,0
62,BMS-536924,BMS 536924,"IGF1R, IR",IGFR signaling,10390396,480.0,"'N', 'O', 'H', 'C', 'Cl'",10,0,2.7,0.0,98.2,856.0,4,7,5,34,1,1,0,1,1,C25H26ClN5O3,CC1=CC(=CC2=C1NC(=C3C(=CC=NC3=O)NCC(C4=CC(=CC=C4)Cl)O)N2)N5CCOCC5,"InChI=1S/C25H26ClN5O3/c1-15-11-18(31-7-9-34-10-8-31)13-20-23(15)30-24(29-20)22-19(5-6-27-25(22)33)28-14-21(32)16-3-2-4-17(26)12-16/h2-6,11-13,21,28-30,32H,7-10,14H2,1H3/b24-22+/t21-/m1/s1",UGQMURPIMYALPH-PZJQAWQVSA-N,0,0,1,0,1,0,1,0,0,0
63,BMS-509744,"KIN001-127, ITK inhibitor",ITK,Other,20635522,609.8,"'N', 'O', 'H', 'C', 'S'",11,0,4.7,0.0,157.0,910.0,2,8,10,42,1,0,1,0,1,C31H39N5O4S2,CC1=CC(=C(C=C1SC2=CN=C(S2)NC(=O)C3=CC=C(C=C3)CNC(C)C(C)C)C(=O)N4CCN(CC4)C(=O)C)OC,"InChI=1S/C31H39N5O4S2/c1-19(2)21(4)32-17-23-7-9-24(10-8-23)29(38)34-31-33-18-28(42-31)41-27-16-25(26(40-6)15-20(27)3)30(39)36-13-11-35(12-14-36)22(5)37/h7-10,15-16,18-19,21,32H,11-14,17H2,1-6H3,(H,33,34,38)",RRHONYZEMUNMJX-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
64,CMK,KIN001-128,RSK2,ERK MAPK signaling,16663089,358.8,"'N', 'O', 'H', 'C', 'Cl'",8,0,2.5,0.0,94.0,458.0,2,5,6,25,0,0,0,0,1,C18H19ClN4O2,CC1=CC=C(C=C1)C2=C(N(C3=NC=NC(=C23)N)CCCO)C(=O)CCl,"InChI=1S/C18H19ClN4O2/c1-11-3-5-12(6-4-11)14-15-17(20)21-10-22-18(15)23(7-2-8-24)16(14)13(25)9-19/h3-6,10,24H,2,7-9H2,1H3,(H2,20,21,22)",PELFTNQHGSITLB-UHFFFAOYSA-N,0,0,1,0,1,0,1,0,0,0
71,Pyrimethamine,"Daraprim, Chloridine",Dihydrofolate reductase (DHFR),Other,4993,248.71,"'C', 'N', 'H', 'Cl'",6,0,2.7,0.0,77.8,243.0,2,4,2,17,0,0,0,0,1,C12H13ClN4,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,"InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7/h3-6H,2H2,1H3,(H4,14,15,16,17)",WKSAUQYGYAYLPV-UHFFFAOYSA-N,0,0,1,0,0,0,1,0,0,0
83,JW-7-52-1,,MTOR,PI3K/MTOR signaling,49836027,607.6,"'N', 'O', 'H', 'C', 'F'",16,0,6.0,0.0,69.6,1110.0,0,8,4,45,0,0,0,0,1,C35H28F3N5O2,CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F,"InChI=1S/C35H28F3N5O2/c1-2-32(44)42-15-13-41(14-16-42)31-11-9-26(19-28(31)35(36,37)38)43-33(45)12-8-24-20-40-30-10-7-22(18-27(30)34(24)43)25-17-23-5-3-4-6-29(23)39-21-25/h3-12,17-21H,2,13-16H2,1H3",AKCRNFFTGXBONI-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
86,A-443654,KIN001-139,"AKT1, AKT2, AKT3",PI3K/MTOR signaling,10172943,397.5,"'C', 'N', 'H', 'O'",11,0,3.7,0.0,92.6,562.0,3,4,6,30,1,1,0,0,1,C24H23N5O,CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OCC(CC4=CNC5=CC=CC=C54)N,"InChI=1S/C24H23N5O/c1-15-22-10-16(6-7-24(22)29-28-15)17-9-20(13-26-11-17)30-14-19(25)8-18-12-27-23-5-3-2-4-21(18)23/h2-7,9-13,19,27H,8,14,25H2,1H3,(H,28,29)/t19-/m0/s1",YWTBGJGMTBHQTM-IBGZPJMESA-N,0,0,1,0,1,0,0,0,0,0
87,GW843682X,GW843682X (AN-13),PLK1,Cell cycle,9826308,477.5,"'N', 'O', 'H', 'C', 'S', 'F'",10,0,4.6,0.0,117.0,688.0,1,9,7,33,0,0,0,0,1,C22H18F3N3O4S,COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",JSKUWFIZUALZLX-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,1,0
88,Entinostat,MS-275,"HDAC1, HDAC3",Chromatin histone acetylation,4261,376.4,"'C', 'N', 'H', 'O'",11,0,2.0,0.0,106.0,508.0,3,5,7,28,0,0,0,0,1,C21H20N4O3,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,"InChI=1S/C21H20N4O3/c22-18-5-1-2-6-19(18)25-20(26)17-9-7-15(8-10-17)13-24-21(27)28-14-16-4-3-11-23-12-16/h1-12H,13-14,22H2,(H,24,27)(H,25,26)",INVTYAOGFAGBOE-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
89,Parthenolide,-,HDAC1,Chromatin histone acetylation,7251185,248.32,"'C', 'H', 'O'",3,0,2.3,0.0,38.8,437.0,0,3,0,18,4,4,0,1,1,C15H20O3,CC1=CCCC2(C(O2)C3C(CC1)C(=C)C(=O)O3)C,"InChI=1S/C15H20O3/c1-9-5-4-8-15(3)13(18-15)12-11(7-6-9)10(2)14(16)17-12/h5,11-13H,2,4,6-8H2,1,3H3/b9-5+/t11-,12-,13+,15+/m0/s1",KTEXNACQROZXEV-PVLRGYAZSA-N,0,0,0,0,1,0,0,0,0,0
91,GSK319347A,"KIN001-135, IKK-3 inhibitor",IKK,Other,11626927,469.5,"'N', 'O', 'H', 'C', 'S'",11,1,3.8,0.0,140.0,797.0,0,8,7,32,0,0,0,0,1,C22H19N3O5S2,COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",LDTAHRLHGHFHKP-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
94,TGX221,"TGX-221, Tgx 221",PI3Kbeta,PI3K/MTOR signaling,9907093,364.4,"'C', 'N', 'H', 'O'",8,0,1.9,0.0,57.2,710.0,1,5,4,27,1,0,1,0,1,C21H24N4O2,CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3)N4CCOCC4,"InChI=1S/C21H24N4O2/c1-15-12-18(16(2)22-17-6-4-3-5-7-17)21-23-19(13-20(26)25(21)14-15)24-8-10-27-11-9-24/h3-7,12-14,16,22H,8-11H2,1-2H3",CPRAGQJXBLMUEL-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
104,Bortezomib,"PS-341, LDP-341, Velcade",Proteasome,Protein stability and degradation,387447,384.2,"'N', 'O', 'H', 'B', 'C'",8,0,,0.0,124.0,500.0,4,6,9,28,2,2,0,0,1,C19H25BN4O4,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",GXJABQQUPOEUTA-RDJZCZTQSA-N,0,0,1,0,1,1,0,0,0,0
106,XMD8-85,ERK5-IN-1,"ERK5, BET",Other,46844147,459.5,"'C', 'N', 'H', 'O'",10,0,3.1,0.0,77.1,703.0,1,8,4,34,0,0,0,0,1,C25H29N7O2,CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C)OC,"InChI=1S/C25H29N7O2/c1-29-11-13-32(14-12-29)17-9-10-19(22(15-17)34-4)27-25-26-16-21-23(28-25)30(2)20-8-6-5-7-18(20)24(33)31(21)3/h5-10,15-16H,11-14H2,1-4H3,(H,26,27,28)",DDTPGANIPBKTNU-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
110,Seliciclib,"Roscovitine, CYC-202, AL-39256","CDK2, CDK7, CDK9",Cell cycle,160355,354.4,"'C', 'N', 'H', 'O'",7,0,3.2,0.0,87.9,417.0,3,6,8,26,1,1,0,0,1,C19H26N6O,CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3,"InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1",BTIHMVBBUGXLCJ-OAHLLOKOSA-N,0,0,1,0,1,0,0,0,0,0
111,Salubrinal,EIF-2alpha Inhibitor,EIF2A,Other,5717801,479.8,"'N', 'O', 'H', 'C', 'Cl', 'S'",11,0,5.2,0.0,98.1,622.0,3,3,5,30,1,0,1,1,1,C21H17Cl3N4OS,C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3,"InChI=1S/C21H17Cl3N4OS/c22-21(23,24)19(27-17(29)12-11-14-6-2-1-3-7-14)28-20(30)26-16-10-4-8-15-9-5-13-25-18(15)16/h1-13,19H,(H,27,29)(H2,26,28,30)/b12-11+",LCOIAYJMPKXARU-VAWYXSNFSA-N,0,0,1,0,1,0,1,1,0,0
119,Lapatinib,"Tykerb, Tyverb","ERBB2, EGFR",EGFR signaling,208908,581.1,"'N', 'O', 'H', 'C', 'Cl', 'S', 'F'",15,0,5.1,0.0,115.0,898.0,2,9,11,40,0,0,0,0,1,C29H26ClFN4O4S,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,"InChI=1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35)",BCFGMOOMADDAQU-UHFFFAOYSA-N,0,0,1,0,1,0,1,1,1,0
127,GSK269962A,GSK 269962A,"ROCK1, ROCK2",Cytoskeleton,16095342,570.6,"'C', 'N', 'H', 'O'",13,0,2.2,0.0,156.0,860.0,2,11,10,42,0,0,0,0,1,C29H30N8O5,CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",YOVNFNXUCOWYSG-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
133,Doxorubicin,"Doxil, Rubex, Adriamycin, Adriablastin, Doxorubicine",Anthracycline,DNA replication,31703,543.5,"'C', 'N', 'H', 'O'",9,0,1.3,0.0,206.0,977.0,6,12,5,39,6,6,0,0,1,C27H29NO11,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,"InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1",AOJJSUZBOXZQNB-TZSSRYMLSA-N,0,0,1,0,1,0,0,0,0,0
134,Etoposide,"Etopophos, Vepesid, Eposin, VP-16",TOP2,DNA replication,36462,588.6,"'C', 'H', 'O'",7,0,0.6,0.0,161.0,969.0,3,13,5,42,10,10,0,0,1,C29H32O13,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,"InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1",VJJPUSNTGOMMGY-MRVIYFEKSA-N,0,0,0,0,1,0,0,0,0,0
135,Gemcitabine,"Gemzar, LY-188011",Pyrimidine antimetabolite,DNA replication,60750,263.2,"'N', 'O', 'H', 'C', 'F'",3,0,-1.5,0.0,108.0,426.0,3,6,2,18,3,3,0,0,1,C9H11F2N3O4,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,"InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1",SDUQYLNIPVEERB-QPPQHZFASA-N,0,0,1,0,1,0,0,0,1,0
136,Mitomycin-C,"Mytozytrex, NSC-26980, MMC, Mitosol, Mitozytrex",DNA crosslinker,DNA replication,5746,334.33,"'C', 'N', 'H', 'O'",5,0,-0.4,0.0,147.0,757.0,3,8,4,24,4,4,0,0,1,C15H18N4O5,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,"InChI=1S/C15H18N4O5/c1-5-9(16)12(21)8-6(4-24-14(17)22)15(23-2)13-7(18-13)3-19(15)10(8)11(5)20/h6-7,13,18H,3-4,16H2,1-2H3,(H2,17,22)/t6-,7+,13+,15-/m1/s1",NWIBSHFKIJFRCO-WUDYKRTCSA-N,0,0,1,0,1,0,0,0,0,0
140,Vinorelbine,"vinorelbine tartrate, Navelbine, Exelbine",Microtubule destabiliser,Mitosis,5311497,778.9,"'C', 'N', 'H', 'O'",12,0,3.6,0.0,134.0,1690.0,2,11,10,57,8,8,0,0,1,C45H54N4O8,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,"InChI=1S/C45H54N4O8/c1-8-27-19-28-22-44(40(51)55-6,36-30(25-48(23-27)24-28)29-13-10-11-14-33(29)46-36)32-20-31-34(21-35(32)54-5)47(4)38-43(31)16-18-49-17-12-15-42(9-2,37(43)49)39(57-26(3)50)45(38,53)41(52)56-7/h10-15,19-21,28,37-39,46,53H,8-9,16-18,22-25H2,1-7H3/t28-,37-,38+,39+,42+,43+,44-,45-/m0/s1",GBABOYUKABKIAF-IELIFDKJSA-N,0,0,1,0,1,0,0,0,0,0
147,NSC-87877,NSC 87877,"SHP-1 (PTPN6), SHP-2 (PTPN11)",Other,5459322,459.5,"'N', 'O', 'H', 'C', 'S'",15,0,1.4,0.0,180.0,995.0,3,10,4,31,0,0,0,1,1,C19H13N3O7S2,C1=CC2=C(C(=O)C(=NNC3=CC4=C(C=C3)C=C(C=C4)S(=O)(=O)O)C=C2S(=O)(=O)O)N=C1,"InChI=1S/C19H13N3O7S2/c23-19-16(10-17(31(27,28)29)15-2-1-7-20-18(15)19)22-21-13-5-3-12-9-14(30(24,25)26)6-4-11(12)8-13/h1-10,21H,(H,24,25,26)(H,27,28,29)/b22-16+",BIQBDHSYQMHHPU-CJLVFECKSA-N,0,0,1,0,1,0,0,1,0,0
150,Bicalutamide,"ICI-176334, Casodex, Cosudex, ICI 176334",AR,Hormone-related,2375,430.4,"'N', 'O', 'H', 'C', 'S', 'F'",9,1,2.3,0.0,116.0,750.0,2,9,5,29,1,0,1,0,1,C18H14F4N2O4S,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,"InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)",LKJPYSCBVHEWIU-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,1,0
151,QS11,944328-88-5,ARFGAP1,Other,4263900,419.9,"'N', 'O', 'H', 'C', 'Cl'",8,0,3.5,0.0,96.6,589.0,1,6,5,29,1,0,1,0,1,C20H22ClN3O5,CC(C(=O)NC1=C(C=CC(=C1)[N+](=O)[O-])Cl)N2CCC3=CC(=C(C=C3C2)OC)OC,"InChI=1S/C20H22ClN3O5/c1-12(20(25)22-17-10-15(24(26)27)4-5-16(17)21)23-7-6-13-8-18(28-2)19(29-3)9-14(13)11-23/h4-5,8-10,12H,6-7,11H2,1-3H3,(H,22,25)",ZECXNJAZPVQZKR-UHFFFAOYSA-N,0,0,1,0,1,0,1,0,0,0
152,CP466722,"CP-466722, CP 466722, 1080622-86-1",ATM,Genome integrity,44551660,349.3,"'C', 'N', 'H', 'O'",10,0,1.8,0.0,114.0,470.0,1,8,4,26,0,0,0,0,1,C17H15N7O2,COC1=C(C=C2C(=C1)C(=NC=N2)N3C(=NC(=N3)C4=CC=CC=N4)N)OC,"InChI=1S/C17H15N7O2/c1-25-13-7-10-12(8-14(13)26-2)20-9-21-16(10)24-17(18)22-15(23-24)11-5-3-4-6-19-11/h3-9H,1-2H3,(H2,18,22,23)",ILBRKJBKDGCSCB-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
153,Midostaurin,"PKC412, benzoylstaurosporine, CGP-41251","PKC, PPK, FLT1, c-FGR, others",Other,9829523,570.6,"'C', 'N', 'H', 'O'",14,0,4.8,0.0,77.7,1140.0,1,4,3,43,4,4,0,0,1,C35H30N4O4,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,"InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1",BMGQWWVMWDBQGC-IIFHNQTCSA-N,0,0,1,0,1,0,0,0,0,0
154,CHIR-99021,"CT 99021, CHIR99021, CHIR 99021","GSK3A, GSK3B",WNT signaling,9956119,465.3,"'C', 'N', 'H', 'Cl'",11,1,4.3,0.0,115.0,645.0,3,7,7,32,0,0,0,0,1,C22H18Cl2N8,CC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N,"InChI=1S/C22H18Cl2N8/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32)",AQGNHMOJWBZFQQ-UHFFFAOYSA-N,0,0,1,0,0,0,1,0,0,0
155,Ponatinib,"AP24534, AP-24534, KIN001-192, Iclusig","ABL, PDGFRA, VEGFR2, FGFR1, SRC, TIE2, FLT3",RTK signaling,24826799,532.6,"'N', 'O', 'H', 'C', 'F'",11,1,4.1,0.0,65.8,910.0,1,8,6,39,0,0,0,0,1,C29H27F3N6O,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,"InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)",PHXJVRSECIGDHY-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
156,AZD6482,"AZD 6482, AZD-6482, AK-55409",PI3Kbeta,PI3K/MTOR signaling,44137675,408.4,"'C', 'N', 'H', 'O'",9,0,2.0,0.0,94.5,838.0,2,7,5,30,1,1,0,0,1,C22H24N4O4,CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3C(=O)O)N4CCOCC4,"InChI=1S/C22H24N4O4/c1-14-11-17(15(2)23-18-6-4-3-5-16(18)22(28)29)21-24-19(12-20(27)26(21)13-14)25-7-9-30-10-8-25/h3-6,11-13,15,23H,7-10H2,1-2H3,(H,28,29)/t15-/m1/s1",IRTDIKMSKMREGO-OAHLLOKOSA-N,0,0,1,0,1,0,0,0,0,0
157,JNK-9L,"KIN001-204, JNK inhibitor 9l","JNK2, JNK3",JNK and p38 signaling,25222038,502.5,"'N', 'O', 'H', 'C', 'F'",11,0,3.4,0.0,93.5,704.0,1,10,6,37,0,0,0,0,1,C26H27FN8O2,C1COCCN1C2=CC(=CC(=C2)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5C=NC(=N5)N6CCOCC6)F,"InChI=1S/C26H27FN8O2/c27-20-15-19(16-23(17-20)33-7-11-36-12-8-33)24-5-6-28-25(31-24)30-21-1-3-22(4-2-21)35-18-29-26(32-35)34-9-13-37-14-10-34/h1-6,15-18H,7-14H2,(H,28,30,31)",AHMHIFXJPSHHPH-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
158,PF-562271,PF-00562271,"FAK, FAK2",Cytoskeleton,11713159,507.5,"'N', 'O', 'H', 'C', 'S', 'F'",12,0,2.0,0.0,138.0,856.0,3,12,7,35,0,0,0,0,1,C21H20F3N7O3S,CN(C1=C(C=CC=N1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C,"InChI=1S/C21H20F3N7O3S/c1-31(35(2,33)34)19-12(4-3-7-25-19)10-26-18-15(21(22,23)24)11-27-20(30-18)28-14-5-6-16-13(8-14)9-17(32)29-16/h3-8,11H,9-10H2,1-2H3,(H,29,32)(H2,26,27,28,30)",MZDKLVOWGIOKTN-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,1,0
159,HG6-64-1,KIN001-206,BRAF,ERK MAPK signaling,53302361,577.6,"'N', 'O', 'H', 'C', 'F'",12,0,5.7,0.0,73.5,911.0,2,8,8,42,0,0,0,1,1,C32H34F3N5O2,CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)C3=CC(=C(C=C3)C)C=CC4=CN=C5C(=C4OC)C=CN5)C(F)(F)F,"InChI=1S/C32H34F3N5O2/c1-4-39-13-15-40(16-14-39)20-25-9-10-26(18-28(25)32(33,34)35)38-31(41)23-6-5-21(2)22(17-23)7-8-24-19-37-30-27(11-12-36-30)29(24)42-3/h5-12,17-19H,4,13-16,20H2,1-3H3,(H,36,37)(H,38,41)/b8-7+",UMBFDGUGXMOMHX-BQYQJAHWSA-N,0,0,1,0,1,0,0,0,1,0
163,JQ1,"JQ-1, (+)-JQ-1","BRD2, BRD3, BRD4, BRDT",Chromatin other,46907787,457.0,"'N', 'O', 'H', 'C', 'Cl', 'S'",9,0,4.9,0.0,97.6,706.0,0,6,5,31,1,1,0,0,1,C23H25ClN4O2S,CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C,"InChI=1S/C23H25ClN4O2S/c1-12-13(2)31-22-19(12)20(15-7-9-16(24)10-8-15)25-17(11-18(29)30-23(4,5)6)21-27-26-14(3)28(21)22/h7-10,17H,11H2,1-6H3/t17-/m0/s1",DNVXATUJJDPFDM-KRWDZBQOSA-N,0,0,1,0,1,0,1,1,0,0
165,DMOG,Dimethyloxalylglcine,HIF-PH,Metabolism,560326,175.14,"'C', 'N', 'H', 'O'",3,0,-0.3,0.0,81.7,200.0,1,5,5,12,0,0,0,0,1,C6H9NO5,COC(=O)CNC(=O)C(=O)OC,"InChI=1S/C6H9NO5/c1-11-4(8)3-7-5(9)6(10)12-2/h3H2,1-2H3,(H,7,9)",BNJOZDZCRHCODO-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
166,FTI-277,-,Farnesyl-transferase (FNTA),Other,3005532,447.6,"'N', 'O', 'H', 'C', 'S'",8,0,3.2,0.0,120.0,532.0,4,7,12,30,2,2,0,0,1,C22H29N3O3S2,COC(=O)C(CCSC)NC(=O)C1=C(C=C(C=C1)NCC(CS)N)C2=CC=CC=C2,"InChI=1S/C22H29N3O3S2/c1-28-22(27)20(10-11-30-2)25-21(26)18-9-8-17(24-13-16(23)14-29)12-19(18)15-6-4-3-5-7-15/h3-9,12,16,20,24,29H,10-11,13-14,23H2,1-2H3,(H,25,26)/t16-,20+/m1/s1",GKFPROVOIQKYTO-UZLBHIALSA-N,0,0,1,0,1,0,0,1,0,0
167,OSU-03012,"AR-12, OSU 03012, OSU03012, PDK1 inhibitor AR-12",PDK1 (PDPK1),"Other, kinases",10027278,460.4,"'N', 'O', 'H', 'C', 'F'",13,0,5.2,0.0,72.9,711.0,2,6,4,34,0,0,0,0,1,C26H19F3N4O,C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F,"InChI=1S/C26H19F3N4O/c27-26(28,29)24-14-23(33(32-24)20-10-8-19(9-11-20)31-25(34)15-30)18-7-12-22-17(13-18)6-5-16-3-1-2-4-21(16)22/h1-14H,15,30H2,(H,31,34)",YULUCECVQOCQFQ-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
170,Shikonin,Anchusin,not defined,Other,5208,288.29,"'C', 'H', 'O'",7,0,3.0,0.0,94.8,501.0,3,5,3,21,1,0,1,0,1,C16H16O5,CC(=CCC(C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C,"InChI=1S/C16H16O5/c1-8(2)3-4-10(17)9-7-13(20)14-11(18)5-6-12(19)15(14)16(9)21/h3,5-7,10,17-19H,4H2,1-2H3",NEZONWMXZKDMKF-UHFFFAOYSA-N,0,0,0,0,1,0,0,0,0,0
171,AKT inhibitor VIII,Akti-1/2,"AKT1, AKT2, AKT3",PI3K/MTOR signaling,10196499,551.6,"'C', 'N', 'H', 'O'",16,0,5.0,0.0,90.0,927.0,2,5,5,42,0,0,0,0,1,C34H29N7O,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=NC6=C(C=C7C(=C6)NC=N7)N=C5C8=CC=CC=C8,"InChI=1S/C34H29N7O/c42-34-39-26-8-4-5-9-31(26)41(34)25-14-16-40(17-15-25)20-22-10-12-24(13-11-22)33-32(23-6-2-1-3-7-23)37-29-18-27-28(36-21-35-27)19-30(29)38-33/h1-13,18-19,21,25H,14-17,20H2,(H,35,36)(H,39,42)",BIWGYFZAEWGBAL-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
172,Embelin,"Emberine, Embelic acid",XIAP,Apoptosis regulation,3218,294.4,"'C', 'H', 'O'",4,0,5.4,0.0,74.6,432.0,2,4,10,21,0,0,0,0,1,C17H26O4,CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O,"InChI=1S/C17H26O4/c1-2-3-4-5-6-7-8-9-10-11-13-16(20)14(18)12-15(19)17(13)21/h12,18,21H,2-11H2,1H3",IRSFLDGTOHBADP-UHFFFAOYSA-N,0,0,0,0,1,0,0,0,0,0
173,FH535,-,"PPARgamma, PPARdelta",WNT signaling,3463933,361.2,"'N', 'O', 'H', 'C', 'Cl', 'S'",9,0,3.9,0.0,100.0,505.0,1,5,3,22,0,0,0,0,1,C13H10Cl2N2O4S,CC1=C(C=CC(=C1)[N+](=O)[O-])NS(=O)(=O)C2=C(C=CC(=C2)Cl)Cl,"InChI=1S/C13H10Cl2N2O4S/c1-8-6-10(17(18)19)3-5-12(8)16-22(20,21)13-7-9(14)2-4-11(13)15/h2-7,16H,1H3",AXNUEXXEQGQWPA-UHFFFAOYSA-N,0,0,1,0,1,0,1,1,0,0
175,PAC-1,GTPL5238,"Procaspase-3, Procaspase-7",Apoptosis regulation,6753378,392.5,"'C', 'N', 'H', 'O'",9,0,3.8,0.0,64.7,681.0,2,5,8,29,0,0,0,1,1,C23H28N4O2,C=CCC1=CC=CC(=CNNC(=O)CN2CCN(CC2)CC3=CC=CC=C3)C1=O,"InChI=1S/C23H28N4O2/c1-2-7-20-10-6-11-21(23(20)29)16-24-25-22(28)18-27-14-12-26(13-15-27)17-19-8-4-3-5-9-19/h2-6,8-11,16,24H,1,7,12-15,17-18H2,(H,25,28)",XSGXRYNZNGUGEJ-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
176,IPA-3,IPA 3,PAK1,Cytoskeleton,521106,350.5,"'C', 'S', 'H', 'O'",10,0,5.8,0.0,91.1,380.0,2,4,3,24,0,0,0,0,1,C20H14O2S2,C1=CC=C2C(=C1)C=CC(=C2SSC3=C(C=CC4=CC=CC=C43)O)O,"InChI=1S/C20H14O2S2/c21-17-11-9-13-5-1-3-7-15(13)19(17)23-24-20-16-8-4-2-6-14(16)10-12-18(20)22/h1-12,21-22H",RFAXLXKIAKIUDT-UHFFFAOYSA-N,0,0,0,0,1,0,0,1,0,0
177,GSK650394,"GSK-650394, GSK 650394","SGK2, SGK3",Other,25022668,382.5,"'C', 'N', 'H', 'O'",11,0,6.1,0.0,66.0,569.0,2,3,4,29,0,0,0,0,1,C25H22N2O2,C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=C3C=C(C=N4)C5=CC=CC=C5)C(=O)O,"InChI=1S/C25H22N2O2/c28-25(29)20-11-10-18(12-21(20)17-8-4-5-9-17)23-15-27-24-22(23)13-19(14-26-24)16-6-2-1-3-7-16/h1-3,6-7,10-15,17H,4-5,8-9H2,(H,26,27)(H,28,29)",WVSBGSNVCDAMCF-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
178,BAY-61-3606,"Syk Inhibitor, BAY-613606",SYK,"Other, kinases",10200390,390.4,"'C', 'N', 'H', 'O'",11,0,3.3,0.0,117.0,566.0,2,7,6,29,0,0,0,0,1,C20H18N6O3,COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC,"InChI=1S/C20H18N6O3/c1-28-15-6-5-12(10-16(15)29-2)14-11-17-22-8-9-26(17)20(24-14)25-19-13(18(21)27)4-3-7-23-19/h3-11H,1-2H3,(H2,21,27)(H,23,24,25)",JWQOJVOKBAAAAR-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
179,5-Fluorouracil,5-FU,Antimetabolite (DNA & RNA),Other,3385,130.08,"'N', 'O', 'H', 'C', 'F'",3,0,-0.9,0.0,58.2,199.0,2,3,0,9,0,0,0,0,1,C4H3FN2O2,C1=C(C(=O)NC(=O)N1)F,"InChI=1S/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)",GHASVSINZRGABV-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
180,Thapsigargin,Octanoic acid,SERCA,Other,446378,650.8,"'C', 'H', 'O'",7,0,3.6,0.0,172.0,1270.0,2,12,17,46,8,8,0,1,1,C34H50O12,CCCCCCCC(=O)OC1C2C(=C(C1OC(=O)C(=CC)C)C)C3C(C(CC2(C)OC(=O)C)OC(=O)CCC)(C(C(=O)O3)(C)O)O,"InChI=1S/C34H50O12/c1-9-12-13-14-15-17-24(37)43-28-26-25(20(5)27(28)44-30(38)19(4)11-3)29-34(41,33(8,40)31(39)45-29)22(42-23(36)16-10-2)18-32(26,7)46-21(6)35/h11,22,26-29,40-41H,9-10,12-18H2,1-8H3/b19-11-/t22-,26+,27-,28-,29-,32-,33+,34+/m0/s1",IXFPJGBNCFXKPI-FSIHEZPISA-N,0,0,0,0,1,0,0,0,0,0
182,Obatoclax Mesylate,"GX15-070MS, Obatoclax, GX15-070","BCL2, BCL-XL, BCL-W, MCL1",Apoptosis regulation,11404337,317.4,"'C', 'N', 'H', 'O'",9,0,3.3,0.0,49.4,777.0,2,3,2,24,0,0,0,2,1,C20H19N3O,CC1=CC(=C(N1)C=C2C(=CC(=C3C=C4C=CC=CC4=N3)N2)OC)C,"InChI=1S/C20H19N3O/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17/h4-11,21,23H,1-3H3/b18-17-,19-10-",CVCLJVVBHYOXDC-IAZSKANUSA-N,0,0,1,0,1,0,0,0,0,0
184,BMS-754807,"BMS754807, BMS 754807","IGF1R, IR",IGFR signaling,24785538,461.5,"'N', 'O', 'H', 'C', 'F'",10,0,2.9,0.0,116.0,756.0,3,8,6,34,1,1,0,0,1,C23H24FN9O,CC1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F,"InChI=1S/C23H24FN9O/c1-23(21(34)26-15-7-8-18(24)25-13-15)9-3-10-32(23)22-28-20(17-4-2-11-33(17)31-22)27-19-12-16(29-30-19)14-5-6-14/h2,4,7-8,11-14H,3,5-6,9-10H2,1H3,(H,26,34)(H2,27,28,29,30,31)/t23-/m0/s1",LQVXSNNAFNGRAH-QHCPKHFHSA-N,0,0,1,0,1,0,0,0,1,0
185,Linsitinib,"OSI-906, ASP-7487",IGF1R,IGFR signaling,11640390,421.5,"'C', 'N', 'H', 'O'",12,0,4.2,0.0,89.3,663.0,2,5,3,32,0,0,0,0,1,C26H23N5O,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,"InChI=1S/C26H23N5O/c1-26(32)14-19(15-26)25-30-22(23-24(27)28-11-12-31(23)25)18-8-7-17-9-10-20(29-21(17)13-18)16-5-3-2-4-6-16/h2-13,19,32H,14-15H2,1H3,(H2,27,28)",PKCDDUHJAFVJJB-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
186,Bexarotene,"LG-100069, Targretin, Targret, Targrexin, Targretyn, Bexarotenum",Retinioic X receptor (RXR) agonist,Other,82146,348.5,"'C', 'H', 'O'",8,0,7.6,0.0,37.3,551.0,1,2,3,26,0,0,0,0,1,C24H28O2,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,"InChI=1S/C24H28O2/c1-15-13-20-21(24(5,6)12-11-23(20,3)4)14-19(15)16(2)17-7-9-18(10-8-17)22(25)26/h7-10,13-14H,2,11-12H2,1,3-6H3,(H,25,26)",NAVMQTYZDKMPEU-UHFFFAOYSA-N,0,0,0,0,1,0,0,0,0,0
190,Bleomycin,-,dsDNA break induction,DNA replication,5360373,1415.6,"'N', 'O', 'H', 'C', 'S'",17,0,-7.5,1.0,685.0,2580.0,20,31,36,96,19,9,10,0,1,C55H84N17O21S3+,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,"InChI=1S/C55H83N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81H,7-13,15-16,56H2,1-6H3,(H13-,57,58,59,60,61,62,63,65,66,69,70,71,72,76,82,83,84,85,86,87,88)/p+1/t21-,22+,23+,24-,25-,29?,30?,34-,35-,36-,37?,38?,39?,40?,41-,42?,43?,53?,54?/m0/s1",OYVAGSVQBOHSSS-WXFSZRTFSA-O,0,0,1,0,1,0,0,1,0,0
192,LFM-A13,DDE-28,BTK,"Other, kinases",54676905,360.0,"'Br', 'N', 'O', 'H', 'C'",5,1,3.8,0.0,73.1,386.0,2,3,2,17,0,0,0,1,1,C11H8Br2N2O2,CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O,"InChI=1S/C11H8Br2N2O2/c1-6(16)8(5-14)11(17)15-10-4-7(12)2-3-9(10)13/h2-4,16H,1H3,(H,15,17)/b8-6-",UVSVTDVJQAJIFG-VURMDHGXSA-N,0,1,1,0,1,1,0,0,0,0
193,GW-2580,"GX2580, CFMS receptor tyrosine kinase inhibitor",CSF1R,RTK signaling,11617559,366.4,"'C', 'N', 'H', 'O'",9,0,2.6,0.0,106.0,433.0,2,7,7,27,0,0,0,0,1,C20H22N4O3,COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC,"InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)",MYQAUKPBNJWPIE-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
194,Luminespib,"AUY922, VER-52296,NVP-AUY922,  AUY",HSP90,Protein stability and degradation,10096043,465.5,"'C', 'N', 'H', 'O'",9,0,2.3,0.0,100.0,932.0,3,7,6,34,0,0,0,1,1,C26H31N3O5,CCNC(=O)C1=C(C(=C2C=C(C(=CC2=O)O)C(C)C)ON1)C3=CC=C(C=C3)CN4CCOCC4,"InChI=1S/C26H31N3O5/c1-4-27-26(32)24-23(18-7-5-17(6-8-18)15-29-9-11-33-12-10-29)25(34-28-24)20-13-19(16(2)3)21(30)14-22(20)31/h5-8,13-14,16,28,30H,4,9-12,15H2,1-3H3,(H,27,32)/b25-20-",SWDZPNJZKUGIIH-QQTULTPQSA-N,0,0,1,0,1,0,0,0,0,0
196,Phenformin,DBI,Biguanide agent,Other,8249,205.26,"'C', 'N', 'H'",5,0,-0.8,0.0,103.0,236.0,3,1,4,15,0,0,0,0,1,C10H15N5,C1=CC=C(C=C1)CCN=C(N)N=C(N)N,"InChI=1S/C10H15N5/c11-9(12)15-10(13)14-7-6-8-4-2-1-3-5-8/h1-5H,6-7H2,(H6,11,12,13,14,15)",ICFJFFQQTFMIBG-UHFFFAOYSA-N,0,0,1,0,0,0,0,0,0,0
197,Bryostatin 1,Bryostatin,PKC,"Other, kinases",5280757,905.0,"'C', 'H', 'O'",10,0,4.0,0.0,240.0,1830.0,4,17,13,64,11,11,0,5,1,C47H68O17,CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O,"InChI=1S/C47H68O17/c1-10-11-12-13-14-15-39(51)62-43-31(22-41(53)58-9)21-34-25-37(28(2)48)61-42(54)24-32(50)23-35-26-38(59-29(3)49)45(6,7)46(55,63-35)27-36-19-30(20-40(52)57-8)18-33(60-36)16-17-44(4,5)47(43,56)64-34/h12-17,20,22,28,32-38,43,48,50,55-56H,10-11,18-19,21,23-27H2,1-9H3/b13-12+,15-14+,17-16+,30-20+,31-22+/t28-,32-,33+,34+,35-,36+,37-,38+,43+,46+,47-/m1/s1",MJQUEDHRCUIRLF-TVIXENOKSA-N,0,0,0,0,1,0,0,0,0,0
199,Pazopanib,Votrient,"CSF1R, KIT,  PDGFRA, PDGFRB",RTK signaling,10113978,437.5,"'N', 'O', 'H', 'C', 'S'",12,0,3.1,0.0,127.0,717.0,2,8,5,31,0,0,0,0,1,C21H23N7O2S,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,"InChI=1S/C21H23N7O2S/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25)",CUIHSIWYWATEQL-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
200,Dacinostat,"NVP-LAQ824, LAQ824",HDAC1,Chromatin histone acetylation,6445533,379.5,"'C', 'N', 'H', 'O'",9,0,2.6,0.0,88.6,505.0,4,4,9,28,0,0,0,1,1,C22H25N3O3,C1=CC=C2C(=C1)C(=CN2)CCN(CCO)CC3=CC=C(C=C3)C=CC(=O)NO,"InChI=1S/C22H25N3O3/c26-14-13-25(12-11-19-15-23-21-4-2-1-3-20(19)21)16-18-7-5-17(6-8-18)9-10-22(27)24-28/h1-10,15,23,26,28H,11-14,16H2,(H,24,27)/b10-9+",BWDQBBCUWLSASG-MDZDMXLPSA-N,0,0,1,0,1,0,0,0,0,0
201,Epothilone B,"Patupilone, EpoB, EPO906, GNF-PF-193",Microtubule stabiliser,Mitosis,448013,507.7,"'N', 'O', 'H', 'C', 'S'",5,0,4.2,0.0,138.0,816.0,2,8,2,35,7,7,0,1,1,C27H41NO6S,CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,"InChI=1S/C27H41NO6S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)33-23(30)13-21(29)26(5,6)25(32)17(3)24(15)31/h11,14-15,17,20-22,24,29,31H,8-10,12-13H2,1-7H3/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1",QXRSDHAAWVKZLJ-PVYNADRNSA-N,0,0,1,0,1,0,0,1,0,0
202,GSK1904529A,"GSK-1904529A, GSK 1904529A","IGF1R, IR",IGFR signaling,25124816,852.0,"'N', 'O', 'H', 'C', 'S', 'F'",19,0,6.8,0.0,155.0,1530.0,2,14,12,61,0,0,0,0,1,C44H47F2N9O5S,CCC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)S(=O)(=O)C)OC)NC4=NC=CC(=N4)C5=C(N=C6N5C=CC=C6)C7=CC(=C(C=C7)OC)C(=O)NC8=C(C=CC=C8F)F,"InChI=1S/C44H47F2N9O5S/c1-5-28-26-35(38(60-3)27-36(28)53-19-15-30(16-20-53)52-21-23-54(24-22-52)61(4,57)58)49-44-47-17-14-34(48-44)42-40(50-39-11-6-7-18-55(39)42)29-12-13-37(59-2)31(25-29)43(56)51-41-32(45)9-8-10-33(41)46/h6-14,17-18,25-27,30H,5,15-16,19-24H2,1-4H3,(H,51,56)(H,47,48,49)",MOSKATHMXWSZTQ-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,1,0
203,BMS-345541,"BMS345541, IKK Inhibitor 3","IKK1, IKK2","Other, kinases",9813758,255.32,"'C', 'N', 'H'",6,0,2.3,0.0,68.2,310.0,2,4,3,19,0,0,0,0,1,C14H17N5,CC1=CC2=C(C=C1)N=C(C3=NC=C(N23)C)NCCN,"InChI=1S/C14H17N5/c1-9-3-4-11-12(7-9)19-10(2)8-17-14(19)13(18-11)16-6-5-15/h3-4,7-8H,5-6,15H2,1-2H3,(H,16,18)",PSPFQEBFYXJZEV-UHFFFAOYSA-N,0,0,1,0,0,0,0,0,0,0
204,Tipifarnib,Zarnestra,Farnesyl-transferase (FNTA),Other,159324,489.4,"'N', 'O', 'H', 'C', 'Cl'",13,0,4.1,0.0,64.2,785.0,1,3,4,34,1,1,0,0,1,C27H22Cl2N4O,CN1C=NC=C1C(C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N,"InChI=1S/C27H22Cl2N4O/c1-32-16-31-15-25(32)27(30,18-6-9-20(28)10-7-18)19-8-11-24-23(13-19)22(14-26(34)33(24)2)17-4-3-5-21(29)12-17/h3-16H,30H2,1-2H3/t27-/m1/s1",PLHJCIYEEKOWNM-HHHXNRCGSA-N,0,0,1,0,1,0,1,0,0,0
205,Avagacestat,"BMS-708163, BMS 708163","Amyloid beta20, Amyloid beta40",Other,46883536,520.9,"'N', 'O', 'H', 'C', 'Cl', 'S', 'F'",11,0,4.0,0.0,128.0,792.0,1,11,9,34,1,1,0,0,1,C20H17ClF4N4O4S,C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)C(CCC(F)(F)F)C(=O)N)Cl,"InChI=1S/C20H17ClF4N4O4S/c21-14-3-5-15(6-4-14)34(31,32)29(17(18(26)30)7-8-20(23,24)25)10-13-2-1-12(9-16(13)22)19-27-11-33-28-19/h1-6,9,11,17H,7-8,10H2,(H2,26,30)/t17-/m1/s1",XEAOPVUAMONVLA-QGZVFWFLSA-N,0,0,1,0,1,0,1,1,1,0
206,Ruxolitinib,"INCB-18424, Ruxolitinib Phosphate, Jakafi","JAK1, JAK2","Other, kinases",25126798,306.4,"'C', 'N', 'H'",6,1,2.1,0.0,83.2,453.0,1,4,4,23,1,1,0,0,1,C17H18N6,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,"InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1",HFNKQEVNSGCOJV-OAHLLOKOSA-N,0,0,1,0,0,0,0,0,0,0
207,AS601245,-,"JNK1, JNK2, JNK2",JNK and p38 signaling,10109823,372.4,"'C', 'S', 'N', 'H'",10,1,3.3,0.0,116.0,522.0,1,7,6,27,1,0,1,0,1,C20H16N6S,C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4,"InChI=1S/C20H16N6S/c21-12-15(19-25-17-5-1-2-6-18(17)27-19)16-8-11-24-20(26-16)23-10-7-14-4-3-9-22-13-14/h1-6,8-9,11,13,15H,7,10H2,(H,23,24,26)",RCYPVQCPYKNSTG-UHFFFAOYSA-N,0,0,1,0,0,0,0,1,0,0
208,Ispinesib Mesylate,SB-715992,KSP,Mitosis,6450816,613.2,"'N', 'O', 'H', 'C', 'Cl', 'S'",14,0,,0.0,142.0,896.0,2,7,9,42,1,1,0,0,2,C31H37ClN4O5S,CC1=CC=C(C=C1)C(=O)N(CCCN)C(C2=NC3=C(C=CC(=C3)Cl)C(=O)N2CC4=CC=CC=C4)C(C)C.CS(=O)(=O)O,"InChI=1S/C30H33ClN4O2.CH4O3S/c1-20(2)27(34(17-7-16-32)29(36)23-12-10-21(3)11-13-23)28-33-26-18-24(31)14-15-25(26)30(37)35(28)19-22-8-5-4-6-9-22;1-5(2,3)4/h4-6,8-15,18,20,27H,7,16-17,19,32H2,1-3H3;1H3,(H,2,3,4)/t27-;/m1./s1",MRKSDPIHUJSKRA-HZPIKELBSA-N,0,0,1,0,1,0,1,1,0,0
219,AT-7519,AT7519,"CDK1, CDK2, CDK4, CDK6, CDK9",Cell cycle,11338033,382.2,"'N', 'O', 'H', 'C', 'Cl'",7,0,2.6,0.0,98.9,479.0,4,4,4,25,0,0,0,0,1,C16H17Cl2N5O2,C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl,"InChI=1S/C16H17Cl2N5O2/c17-10-2-1-3-11(18)13(10)15(24)22-12-8-20-23-14(12)16(25)21-9-4-6-19-7-5-9/h1-3,8-9,19H,4-7H2,(H,20,23)(H,21,25)(H,22,24)",OVPNQJVDAFNBDN-UHFFFAOYSA-N,0,0,1,0,1,0,1,0,0,0
221,TAK-715,"KIN001-201, TAK 715","p38alpha, p38beta",JNK and p38 signaling,9952773,399.5,"'N', 'O', 'H', 'C', 'S'",12,0,5.6,0.0,83.1,538.0,1,4,5,29,0,0,0,0,1,C24H21N3OS,CCC1=NC(=C(S1)C2=CC(=NC=C2)NC(=O)C3=CC=CC=C3)C4=CC=CC(=C4)C,"InChI=1S/C24H21N3OS/c1-3-21-27-22(18-11-7-8-16(2)14-18)23(29-21)19-12-13-25-20(15-19)26-24(28)17-9-5-4-6-10-17/h4-15H,3H2,1-2H3,(H,25,26,28)",HEKAIDKUDLCBRU-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
222,BX-912,-,PDK1 (PDPK1),PI3K/MTOR signaling,11754511,471.4,"'Br', 'N', 'O', 'H', 'C'",9,0,2.9,0.0,111.0,549.0,4,6,7,30,0,0,0,0,1,C20H23BrN8O,C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br,"InChI=1S/C20H23BrN8O/c21-17-12-24-19(28-18(17)23-7-6-16-11-22-13-25-16)26-14-4-3-5-15(10-14)27-20(30)29-8-1-2-9-29/h3-5,10-13H,1-2,6-9H2,(H,22,25)(H,27,30)(H2,23,24,26,28)",DMMILYKXNCVKOJ-UHFFFAOYSA-N,0,1,1,0,1,1,0,0,0,0
223,ZSTK474,"KIN001-167, ZSTK-474, ZSTK 474",PI3K (class 1),PI3K/MTOR signaling,11647372,417.4,"'N', 'O', 'H', 'C', 'F'",7,0,2.3,0.0,81.4,539.0,0,10,4,30,0,0,0,0,1,C19H21F2N7O2,C1COCCN1C2=NC(=NC(=N2)N3C4=CC=CC=C4N=C3C(F)F)N5CCOCC5,"InChI=1S/C19H21F2N7O2/c20-15(21)16-22-13-3-1-2-4-14(13)28(16)19-24-17(26-5-9-29-10-6-26)23-18(25-19)27-7-11-30-12-8-27/h1-4,15H,5-12H2",HGVNLRPZOWWDKD-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
224,AS605240,"KIN001-173, AS-605240",PI3Kgamma,PI3K/MTOR signaling,5289247,257.27,"'N', 'O', 'H', 'C', 'S'",8,0,1.5,0.0,97.2,410.0,1,5,1,18,0,0,0,1,1,C12H7N3O2S,C1=CC2=NC=CN=C2C=C1C=C3C(=O)NC(=O)S3,"InChI=1S/C12H7N3O2S/c16-11-10(18-12(17)15-11)6-7-1-2-8-9(5-7)14-4-3-13-8/h1-6H,(H,15,16,17)/b10-6-",SQWZFLMPDUSYGV-POHAHGRESA-N,0,0,1,0,1,0,0,1,0,0
226,GSK1070916,GSK-1070916,"AURKA, AURKC",Mitosis,46885626,507.6,"'C', 'N', 'H', 'O'",13,0,3.9,0.0,82.1,770.0,2,4,7,38,0,0,0,0,1,C30H33N7O,CCN1C=C(C(=N1)C2=CC=C(C=C2)NC(=O)N(C)C)C3=C4C=C(NC4=NC=C3)C5=CC=CC(=C5)CN(C)C,"InChI=1S/C30H33N7O/c1-6-37-19-26(28(34-37)21-10-12-23(13-11-21)32-30(38)36(4)5)24-14-15-31-29-25(24)17-27(33-29)22-9-7-8-20(16-22)18-35(2)3/h7-17,19H,6,18H2,1-5H3,(H,31,33)(H,32,38)",QTBWCSQGBMPECM-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
228,AKT inhibitor VIII,"Akti-1/2, KIN001-102","AKT1, AKT2, AKT3",PI3K/MTOR signaling,10196499,551.6,"'C', 'N', 'H', 'O'",16,0,5.0,0.0,90.0,927.0,2,5,5,42,0,0,0,0,1,C34H29N7O,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=NC6=C(C=C7C(=C6)NC=N7)N=C5C8=CC=CC=C8,"InChI=1S/C34H29N7O/c42-34-39-26-8-4-5-9-31(26)41(34)25-14-16-40(17-15-25)20-22-10-12-24(13-11-22)33-32(23-6-2-1-3-7-23)37-29-18-27-28(36-21-35-27)19-30(29)38-33/h1-13,18-19,21,25H,14-17,20H2,(H,35,36)(H,39,42)",BIWGYFZAEWGBAL-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
229,Enzastaurin,LY317615,PKCB,"Other, kinases",176167,515.6,"'C', 'N', 'H', 'O'",14,0,3.7,0.0,72.2,974.0,1,4,5,39,0,0,0,0,1,C32H29N5O2,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7,"InChI=1S/C32H29N5O2/c1-35-19-25(23-9-2-4-11-27(23)35)29-30(32(39)34-31(29)38)26-20-37(28-12-5-3-10-24(26)28)22-13-16-36(17-14-22)18-21-8-6-7-15-33-21/h2-12,15,19-20,22H,13-14,16-18H2,1H3,(H,34,38,39)",AXRCEOKUDYDWLF-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
230,GSK429286A,-,"ROCK1, ROCK2",Cytoskeleton,11373846,432.4,"'N', 'O', 'H', 'C', 'F'",10,0,2.9,0.0,86.9,748.0,3,7,3,31,1,0,1,0,1,C21H16F4N4O2,CC1=C(C(CC(=O)N1)C2=CC=C(C=C2)C(F)(F)F)C(=O)NC3=C(C=C4C(=C3)C=NN4)F,"InChI=1S/C21H16F4N4O2/c1-10-19(20(31)28-17-6-12-9-26-29-16(12)8-15(17)22)14(7-18(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-6,8-9,14H,7H2,1H3,(H,26,29)(H,27,30)(H,28,31)",OLIIUAHHAZEXEX-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
231,FMK,KIN001-242,RSK,"Other, kinases",644243,342.4,"'N', 'O', 'H', 'C', 'F'",8,0,2.3,0.0,94.0,458.0,2,6,6,25,0,0,0,0,1,C18H19FN4O2,CC1=CC=C(C=C1)C2=C(N(C3=NC=NC(=C23)N)CCCO)C(=O)CF,"InChI=1S/C18H19FN4O2/c1-11-3-5-12(6-4-11)14-15-17(20)21-10-22-18(15)23(7-2-8-24)16(14)13(25)9-19/h3-6,10,24H,2,7-9H2,1H3,(H2,20,21,22)",IKLGYJACVCXYIL-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
235,QL-XII-47,-,"BTK, BMX","Other, kinases",71748056,447.5,"'C', 'N', 'H', 'O'",14,0,3.3,0.0,71.3,860.0,0,4,3,34,0,0,0,0,1,C27H21N5O2,CN1C=C(C=N1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC6=C(CCN6C(=O)C=C)C=C5,"InChI=1S/C27H21N5O2/c1-3-25(33)31-11-10-17-4-7-21(13-24(17)31)32-26(34)9-6-19-14-28-23-8-5-18(12-22(23)27(19)32)20-15-29-30(2)16-20/h3-9,12-16H,1,10-11H2,2H3",RTRNJQOBEOISFQ-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
238,Idelalisib,"CAL-101, Zydelig",PI3Kdelta,PI3K/MTOR signaling,11625818,415.4,"'N', 'O', 'H', 'C', 'F'",12,0,3.7,0.0,99.2,685.0,2,7,5,31,1,1,0,0,1,C22H18FN7O,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,"InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m0/s1",IFSDAJWBUCMOAH-HNNXBMFYSA-N,0,0,1,0,1,0,0,0,1,0
245,UNC0638,"UNC-0638, UNC 0683",G9a and GLP methyltransferases,Chromatin histone methylation,46224516,509.7,"'C', 'N', 'H', 'O'",5,0,6.3,0.0,62.8,660.0,1,7,10,37,0,0,0,0,1,C30H47N5O2,CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)C5CCCCC5,"InChI=1S/C30H47N5O2/c1-22(2)35-17-12-24(13-18-35)31-30-25-20-27(36-3)28(37-19-9-16-34-14-7-8-15-34)21-26(25)32-29(33-30)23-10-5-4-6-11-23/h20-24H,4-19H2,1-3H3,(H,31,32,33)",QOECJCJVIMVJGX-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
249,Cabozantinib,"BMS-907351, XL-184, Cometriq","VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL","Other, kinases",25102847,501.5,"'N', 'O', 'H', 'C', 'F'",13,0,5.4,0.0,98.8,795.0,2,7,8,37,0,0,0,0,1,C28H24FN3O5,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,"InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34)",ONIQOQHATWINJY-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
252,WZ3105,-,"SRC, ROCK2, NTRK2, FLT3, IRAK1, others",Other,42628507,462.6,"'C', 'N', 'H', 'O'",9,0,4.1,0.0,100.0,680.0,3,7,8,34,0,0,0,0,1,C25H34N8O,CC(C)N1C=NC2=C(N=C(N=C21)NC3CCC(CC3)N(C)C)NC4=CC(=CC=C4)NC(=O)C=C,"InChI=1S/C25H34N8O/c1-6-21(34)27-18-8-7-9-19(14-18)28-23-22-24(33(15-26-22)16(2)3)31-25(30-23)29-17-10-12-20(13-11-17)32(4)5/h6-9,14-17,20H,1,10-13H2,2-5H3,(H,27,34)(H2,28,29,30,31)",DGEBYERMQBTMHV-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
254,Quizartinib,"AC220, AC 220, AC-220, Asp-2689",FLT3,RTK signaling,24889392,560.7,"'N', 'O', 'H', 'C', 'S'",11,0,5.6,0.0,134.0,849.0,2,8,8,40,0,0,0,0,1,C29H32N6O4S,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,"InChI=1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36)",CVWXJKQAOSCOAB-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
255,CP724714,CP-724714,ERBB2,EGFR signaling,9874913,469.5,"'C', 'N', 'H', 'O'",13,0,4.3,0.0,98.3,692.0,2,7,9,35,0,0,0,1,1,C27H27N5O3,CC1=NC=C(C=C1)OC2=C(C=C(C=C2)NC3=NC=NC4=C3C=C(C=C4)C=CCNC(=O)COC)C,"InChI=1S/C27H27N5O3/c1-18-13-21(8-11-25(18)35-22-9-6-19(2)29-15-22)32-27-23-14-20(7-10-24(23)30-17-31-27)5-4-12-28-26(33)16-34-3/h4-11,13-15,17H,12,16H2,1-3H3,(H,28,33)(H,30,31,32)/b5-4+",LLVZBTWPGQVVLW-SNAWJCMRSA-N,0,0,1,0,1,0,0,0,0,0
256,JW-7-24-1,-,LCK,"Other, kinases",69923936,560.6,"'N', 'O', 'H', 'C', 'F'",13,0,5.3,0.0,66.9,932.0,1,9,5,41,0,0,0,0,1,C31H27F3N4O3,COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC,"InChI=1S/C31H27F3N4O3/c1-40-23-13-21(14-24(17-23)41-2)19-3-6-27-25(15-19)30-20(18-36-27)4-8-29(39)38(30)22-5-7-28(26(16-22)31(32,33)34)37-11-9-35-10-12-37/h3-8,13-18,35H,9-12H2,1-2H3",VVTHOUCIAGHQBD-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
257,NPK76-II-72-1,-,PLK3,Cell cycle,46843648,521.7,"'C', 'N', 'H', 'O'",8,0,3.1,0.0,103.0,816.0,2,8,6,38,1,0,1,0,1,C28H39N7O3,CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C,"InChI=1S/C28H39N7O3/c1-18-15-25(36)34(3)23-17-29-28(32-26(23)35(18)21-7-5-6-8-21)31-22-10-9-19(16-24(22)38-4)27(37)30-20-11-13-33(2)14-12-20/h9-10,16-18,20-21H,5-8,11-15H2,1-4H3,(H,30,37)(H,29,31,32)",KZLQLABUFJNPSZ-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
258,STF-62247,STF62247,Autophagy inducer,Other,704473,267.4,"'C', 'S', 'N', 'H'",8,0,3.8,0.0,66.0,281.0,1,4,3,19,0,0,0,0,1,C15H13N3S,CC1=CC(=CC=C1)NC2=NC(=CS2)C3=CC=NC=C3,"InChI=1S/C15H13N3S/c1-11-3-2-4-13(9-11)17-15-18-14(10-19-15)12-5-7-16-8-6-12/h2-10H,1H3,(H,17,18)",KATNUHQNJGNLPW-UHFFFAOYSA-N,0,0,1,0,0,0,0,1,0,0
260,NG-25,NG25,"TAK1, MAP4K2","Other, kinases",53340664,537.6,"'N', 'O', 'H', 'C', 'F'",11,0,4.9,0.0,73.5,808.0,2,8,7,39,0,0,0,0,1,C29H30F3N5O2,CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)C3=CC(=C(C=C3)C)OC4=C5C=CNC5=NC=C4)C(F)(F)F,"InChI=1S/C29H30F3N5O2/c1-3-36-12-14-37(15-13-36)18-21-6-7-22(17-24(21)29(30,31)32)35-28(38)20-5-4-19(2)26(16-20)39-25-9-11-34-27-23(25)8-10-33-27/h4-11,16-17H,3,12-15,18H2,1-2H3,(H,33,34)(H,35,38)",SMPGEBOIKULBCT-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
262,VX-11e,"VX11e, VX11e",ERK2,ERK MAPK signaling,11634725,500.3,"'N', 'O', 'H', 'C', 'Cl', 'F'",12,0,4.7,0.0,103.0,679.0,4,6,7,34,1,1,0,0,1,C24H20Cl2FN5O2,CC1=CN=C(N=C1C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)NC4=C(C=C(C=C4)F)Cl,"InChI=1S/C24H20Cl2FN5O2/c1-13-10-29-24(31-19-6-5-17(27)9-18(19)26)32-22(13)15-8-20(28-11-15)23(34)30-21(12-33)14-3-2-4-16(25)7-14/h2-11,21,28,33H,12H2,1H3,(H,30,34)(H,29,31,32)/t21-/m1/s1",WUTVMXLIGHTZJC-OAQYLSRUSA-N,0,0,1,0,1,0,1,0,1,0
263,FR-180204,"FR 180204, FR180204, ERK Inhibitor II","ERK1, ERK2",ERK MAPK signaling,11493598,327.3,"'C', 'N', 'H'",11,0,1.9,0.0,97.8,468.0,2,5,2,25,0,0,0,0,1,C18H13N7,C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N,"InChI=1S/C18H13N7/c19-17-12-10-13(20-22-18(12)23-21-17)15-14-8-4-5-9-25(14)24-16(15)11-6-2-1-3-7-11/h1-10H,(H3,19,21,22,23)",XVECMUKVOMUNLE-UHFFFAOYSA-N,0,0,1,0,0,0,0,0,0,0
265,Tubastatin A,-,"HDAC1, HDAC6, HDAC8",Chromatin histone acetylation,53394750,411.4,"'N', 'O', 'H', 'C', 'F'",8,1,,0.0,87.0,544.0,3,6,4,30,0,0,0,0,2,C22H22FN3O4,CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=C(C=C4)C(=O)NO.C(#CF)OO,"InChI=1S/C20H21N3O2.C2HFO2/c1-22-11-10-19-17(13-22)16-4-2-3-5-18(16)23(19)12-14-6-8-15(9-7-14)20(24)21-25;3-1-2-5-4/h2-9,25H,10-13H2,1H3,(H,21,24);4H",PXMHOGGXJJXTGA-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
266,Zibotentan,"ZD4054, ZD-4054",Endothelin-1 receptor (EDNRA),Other,9910224,424.4,"'N', 'O', 'H', 'C', 'S'",13,0,1.4,0.0,141.0,654.0,1,10,6,30,0,0,0,0,1,C19H16N6O4S,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,"InChI=1S/C19H16N6O4S/c1-12-10-21-17(19(23-12)28-2)25-30(26,27)15-4-3-9-20-16(15)13-5-7-14(8-6-13)18-24-22-11-29-18/h3-11H,1-2H3,(H,21,25)",FJHHZXWJVIEFGJ-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
268,Sepantronium bromide,"YM155, YM-155, YM 155",BIRC5,Apoptosis regulation,11178236,443.3,"'Br', 'N', 'O', 'H', 'C'",10,0,,0.0,78.0,571.0,0,6,5,28,0,0,0,0,2,C20H19BrN4O3,CC1=[N+](C2=C(N1CCOC)C(=O)C3=CC=CC=C3C2=O)CC4=NC=CN=C4.[Br-],"InChI=1S/C20H19N4O3.BrH/c1-13-23(9-10-27-2)17-18(24(13)12-14-11-21-7-8-22-14)20(26)16-6-4-3-5-15(16)19(17)25;/h3-8,11H,9-10,12H2,1-2H3;1H/q+1;/p-1",QBIYUDDJPRGKNJ-UHFFFAOYSA-M,0,1,1,0,1,1,0,0,0,0
269,NSC-207895,"XI-006, NSC207895",MDM4,p53 pathway,42640,279.25,"'C', 'N', 'H', 'O'",5,0,1.2,0.0,104.0,370.0,0,7,1,20,0,0,0,0,1,C11H13N5O4,CN1CCN(CC1)C2=CC=C(C3=NO[N+](=C23)[O-])[N+](=O)[O-],"InChI=1S/C11H13N5O4/c1-13-4-6-14(7-5-13)9-3-2-8(15(17)18)10-11(9)16(19)20-12-10/h2-3H,4-7H2,1H3",MWFZDJLPWDCQIL-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
271,VNLG/124,HDAC inhibitor XV,"HDAC,RAR",Chromatin histone acetylation,24894414,476.6,"'C', 'H', 'O'",10,0,8.7,0.0,52.6,874.0,0,4,12,35,0,0,0,4,1,C31H40O4,CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C,"InChI=1S/C31H40O4/c1-7-10-29(32)34-22-26-15-17-27(18-16-26)35-30(33)21-24(3)12-8-11-23(2)14-19-28-25(4)13-9-20-31(28,5)6/h8,11-12,14-19,21H,7,9-10,13,20,22H2,1-6H3/b12-8+,19-14+,23-11+,24-21+",GDELUZOQMHQHNF-PFLGVXPYSA-N,0,0,0,0,1,0,0,0,0,0
272,AR-42,"HDAC-42, AR 42, AR42",HDAC1,Chromatin histone acetylation,6918848,312.4,"'C', 'N', 'H', 'O'",8,0,2.8,0.0,78.4,397.0,3,3,5,23,1,1,0,0,1,C18H20N2O3,CC(C)C(C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO,"InChI=1S/C18H20N2O3/c1-12(2)16(13-6-4-3-5-7-13)18(22)19-15-10-8-14(9-11-15)17(21)20-23/h3-12,16,23H,1-2H3,(H,19,22)(H,20,21)/t16-/m0/s1",LAMIXXKAWNLXOC-INIZCTEOSA-N,0,0,1,0,1,0,0,0,0,0
273,CUDC-101,CUDC 101,"HDAC1-10, EGFR, ERBB2",Other,24756910,434.5,"'C', 'N', 'H', 'O'",9,1,4.0,0.0,106.0,624.0,3,7,12,32,0,0,0,0,1,C24H26N4O4,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO,"InChI=1S/C24H26N4O4/c1-3-17-9-8-10-18(13-17)27-24-19-14-22(21(31-2)15-20(19)25-16-26-24)32-12-7-5-4-6-11-23(29)28-30/h1,8-10,13-16,30H,4-7,11-12H2,2H3,(H,28,29)(H,25,26,27)",PLIVFNIUGLLCEK-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
274,Belinostat,"PXD101, PXD-101",HDAC1,Chromatin histone acetylation,6918638,318.3,"'N', 'O', 'H', 'C', 'S'",10,0,1.7,0.0,104.0,492.0,3,5,5,22,0,0,0,1,1,C15H14N2O4S,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,"InChI=1S/C15H14N2O4S/c18-15(16-19)10-9-12-5-4-8-14(11-12)22(20,21)17-13-6-2-1-3-7-13/h1-11,17,19H,(H,16,18)/b10-9+",NCNRHFGMJRPRSK-MDZDMXLPSA-N,0,0,1,0,1,0,0,1,0,0
275,I-BET-762,GSK525762A,"BRD2, BRD3, BRD4",Chromatin other,46943432,423.9,"'N', 'O', 'H', 'C', 'Cl'",10,0,2.9,0.0,81.4,639.0,1,5,5,30,1,1,0,0,1,C22H22ClN5O2,CCNC(=O)CC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C,"InChI=1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m0/s1",AAAQFGUYHFJNHI-SFHVURJKSA-N,0,0,1,0,1,0,1,0,0,0
276,CAY10603,-,"HDAC1, HDAC6",Chromatin histone acetylation,24951314,446.5,"'C', 'N', 'H', 'O'",8,0,2.6,0.0,143.0,616.0,4,7,12,32,0,0,0,0,1,C22H30N4O6,CC(C)(C)OC(=O)NC1=CC=C(C=C1)C2=CC(=NO2)C(=O)NCCCCCCC(=O)NO,"InChI=1S/C22H30N4O6/c1-22(2,3)31-21(29)24-16-11-9-15(10-12-16)18-14-17(26-32-18)20(28)23-13-7-5-4-6-8-19(27)25-30/h9-12,14,30H,4-8,13H2,1-3H3,(H,23,28)(H,24,29)(H,25,27)",WWGBHDIHIVGYLZ-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
277,Linifanib,"ABT-869, ABT 869","VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT",RTK signaling,11485656,375.4,"'N', 'O', 'H', 'C', 'F'",11,0,3.9,0.0,95.8,541.0,4,4,3,28,0,0,0,0,1,C21H18FN5O,CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N,"InChI=1S/C21H18FN5O/c1-12-5-10-16(22)18(11-12)25-21(28)24-14-8-6-13(7-9-14)15-3-2-4-17-19(15)20(23)27-26-17/h2-11H,1H3,(H3,23,26,27)(H2,24,25,28)",MPVGZUGXCQEXTM-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
279,BIX02189,BIX 02189,"MEK5, ERK5",ERK MAPK signaling,46931012,440.5,"'C', 'N', 'H', 'O'",12,0,3.5,0.0,64.7,740.0,2,4,6,33,0,0,0,1,1,C27H28N4O2,CN(C)CC1=CC(=CC=C1)NC(=C2C3=C(C=C(C=C3)C(=O)N(C)C)NC2=O)C4=CC=CC=C4,"InChI=1S/C27H28N4O2/c1-30(2)17-18-9-8-12-21(15-18)28-25(19-10-6-5-7-11-19)24-22-14-13-20(27(33)31(3)4)16-23(22)29-26(24)32/h5-16,28H,17H2,1-4H3,(H,29,32)/b25-24-",HOMJAAIVTDVQJA-IZHYLOQSSA-N,0,0,1,0,1,0,0,0,0,0
281,Alectinib,"CH5424802, CH 542802, Alecensa",ALK,RTK signaling,49806720,482.6,"'C', 'N', 'H', 'O'",8,1,5.2,0.0,72.4,867.0,1,5,3,36,0,0,0,0,1,C30H34N4O2,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,"InChI=1S/C30H34N4O2/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29/h5-6,15-17,21,32H,4,7-14H2,1-3H3",KDGFLJKFZUIJMX-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
282,Pelitinib,"EKB-569, EKB 569",EGFR,EGFR signaling,6445562,467.9,"'N', 'O', 'H', 'C', 'Cl', 'F'",10,1,4.5,0.0,90.3,729.0,2,7,8,33,0,0,0,1,1,C24H23ClFN5O2,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)C=CCN(C)C,"InChI=1S/C24H23ClFN5O2/c1-4-33-22-12-20-17(11-21(22)30-23(32)6-5-9-31(2)3)24(15(13-27)14-28-20)29-16-7-8-19(26)18(25)10-16/h5-8,10-12,14H,4,9H2,1-3H3,(H,28,29)(H,30,32)/b6-5+",WVUNYSQLFKLYNI-AATRIKPKSA-N,0,0,1,0,1,0,1,0,1,0
283,Omipalisib,"GSK2126458, GSK-2126458, EX-8678, GSK458","PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,25167777,505.5,"'N', 'O', 'H', 'C', 'S', 'F'",16,0,3.3,0.0,115.0,833.0,1,10,6,36,0,0,0,0,1,C25H17F2N5O3S,COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F,"InChI=1S/C25H17F2N5O3S/c1-35-25-23(32-36(33,34)24-5-3-18(26)12-21(24)27)11-17(13-29-25)15-2-4-22-20(10-15)19(7-8-28-22)16-6-9-30-31-14-16/h2-14,32H,1H3",CGBJSGAELGCMKE-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,1,0
287,KIN001-244,PDK1 inhibitor 7,PDK1 (PDPK1),"Other, kinases",56965967,516.5,"'N', 'O', 'H', 'C', 'F'",14,0,4.0,0.0,99.8,953.0,3,6,8,38,1,0,1,0,1,C28H22F2N4O4,C1=CC=C(C=C1)C(COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F,"InChI=1S/C28H22F2N4O4/c29-21-10-8-17(13-22(21)30)15-34-12-4-7-20(27(34)36)26(35)31-25(18-5-2-1-3-6-18)16-38-19-9-11-23-24(14-19)33-28(37)32-23/h1-14,25H,15-16H2,(H,31,35)(H2,32,33,37)",GCWCGSPBENFEPE-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
288,WHI-P97,"AC1L1GQE, KIN001-055",JAK3,"Other, kinases",3796,455.1,"'Br', 'N', 'O', 'H', 'C'",8,0,4.4,0.0,76.5,408.0,2,6,4,24,0,0,0,0,1,C16H13Br2N3O3,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C(=C3)Br)O)Br)OC,"InChI=1S/C16H13Br2N3O3/c1-23-13-5-9-12(6-14(13)24-2)19-7-20-16(9)21-8-3-10(17)15(22)11(18)4-8/h3-7,22H,1-2H3,(H,19,20,21)",YVCXQRVVNQMZEI-UHFFFAOYSA-N,0,1,1,0,1,1,0,0,0,0
290,KIN001-260,"Bayer IKKb inhibitor, ACHP",IKKB,Other,10451420,364.4,"'C', 'N', 'H', 'O'",6,1,1.8,0.0,100.0,856.0,3,6,4,27,0,0,0,1,1,C21H24N4O2,C1CC1COC2=CC=CC(=O)C2=C3C=C(C(=C(N3)N)C#N)C4CCNCC4,"InChI=1S/C21H24N4O2/c22-11-16-15(14-6-8-24-9-7-14)10-17(25-21(16)23)20-18(26)2-1-3-19(20)27-12-13-4-5-13/h1-3,10,13-14,24-25H,4-9,12,23H2/b20-17+",DWQVGCQPWXKRKO-LVZFUZTISA-N,0,0,1,0,1,0,0,0,0,0
291,KIN001-266,-,MAP3K8,"Other, kinases",44143370,539.4,"'N', 'H', 'C', 'Cl', 'F'",10,1,5.5,0.0,94.7,792.0,2,8,7,37,0,0,0,0,1,C26H25Cl2FN8,CCN1CCC(CC1)N2C=C(N=N2)CNC3=CC4=C(C(=CN=C4C(=C3)Cl)C#N)NC5=CC(=C(C=C5)F)Cl,"InChI=1S/C26H25Cl2FN8/c1-2-36-7-5-20(6-8-36)37-15-19(34-35-37)14-31-18-9-21-25(33-17-3-4-24(29)22(27)10-17)16(12-30)13-32-26(21)23(28)11-18/h3-4,9-11,13,15,20,31H,2,5-8,14H2,1H3,(H,32,33)",PHNZIIMWDVXPGG-UHFFFAOYSA-N,0,0,1,0,0,0,1,0,1,0
292,Masitinib,"AB1010, Masivet","KIT, PDGFRA, PDGFRB","Other, kinases",10074640,498.6,"'N', 'O', 'H', 'C', 'S'",12,0,4.3,0.0,102.0,696.0,2,7,7,36,0,0,0,0,1,C28H30N6OS,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,"InChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32)",WJEOLQLKVOPQFV-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
293,Amuvatinib,"MP470, MP 470, MP-470","KIT, PDGFRA, FLT3","Other, kinases",11282283,447.5,"'N', 'O', 'H', 'C', 'S'",10,0,3.5,0.0,108.0,678.0,1,7,3,32,0,0,0,0,1,C23H21N5O3S,C1CN(CCN1C2=NC=NC3=C2OC4=CC=CC=C43)C(=S)NCC5=CC6=C(C=C5)OCO6,"InChI=1S/C23H21N5O3S/c32-23(24-12-15-5-6-18-19(11-15)30-14-29-18)28-9-7-27(8-10-28)22-21-20(25-13-26-22)16-3-1-2-4-17(16)31-21/h1-6,11,13H,7-10,12,14H2,(H,24,32)",FOFDIMHVKGYHRU-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
294,MPS-1-IN-1,-,MPS1,Mitosis,25195352,535.7,"'N', 'O', 'H', 'C', 'S'",12,0,5.3,0.0,128.0,862.0,4,8,8,38,0,0,0,0,1,C28H33N5O4S,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC,"InChI=1S/C28H33N5O4S/c1-18(2)38(35,36)26-7-5-4-6-23(26)30-24-17-27(32-28-21(24)10-13-29-28)31-22-9-8-19(16-25(22)37-3)33-14-11-20(34)12-15-33/h4-10,13,16-18,20,34H,11-12,14-15H2,1-3H3,(H3,29,30,31,32)",NMJMRSQTDLRCRQ-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
295,NVP-BHG712,BHG712,EPHB4,Other,16747388,503.5,"'N', 'O', 'H', 'C', 'F'",14,0,4.7,0.0,97.6,786.0,2,9,5,37,0,0,0,0,1,C26H20F3N7O,CC1=C(C=C(C=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)NC3=C4C=NN(C4=NC(=N3)C5=CN=CC=C5)C,"InChI=1S/C26H20F3N7O/c1-15-8-9-16(25(37)32-19-7-3-6-18(12-19)26(27,28)29)11-21(15)33-23-20-14-31-36(2)24(20)35-22(34-23)17-5-4-10-30-13-17/h3-14H,1-2H3,(H,32,37)(H,33,34,35)",ZCCPLJOKGAACRT-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
298,OSI-930,OSI 930 OSI930,KIT,RTK signaling,9868037,443.4,"'N', 'O', 'H', 'C', 'S', 'F'",11,0,6.2,0.0,91.5,601.0,2,8,6,31,0,0,0,0,1,C22H16F3N3O2S,C1=CC=C2C(=C1)C(=CC=N2)CNC3=C(SC=C3)C(=O)NC4=CC=C(C=C4)OC(F)(F)F,"InChI=1S/C22H16F3N3O2S/c23-22(24,25)30-16-7-5-15(6-8-16)28-21(29)20-19(10-12-31-20)27-13-14-9-11-26-18-4-2-1-3-17(14)18/h1-12,27H,13H2,(H,28,29)",FGTCROZDHDSNIO-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,1,0
299,OSI-027,A-1065-5,"MTORC1, MTORC2",PI3K/MTOR signaling,44224160,406.4,"'C', 'N', 'H', 'O'",9,0,2.0,0.0,125.0,1060.0,3,7,3,30,0,0,0,1,1,C21H22N6O3,COC1=CC=CC2=CC(=C3C4=C(N=CNN4C(=N3)C5CCC(CC5)C(=O)O)N)N=C21,"InChI=1S/C21H22N6O3/c1-30-15-4-2-3-13-9-14(25-16(13)15)17-18-19(22)23-10-24-27(18)20(26-17)11-5-7-12(8-6-11)21(28)29/h2-4,9-12H,5-8,22H2,1H3,(H,23,24)(H,28,29)/b17-14-",CDNMDRUIGNHEMR-VKAVYKQESA-N,0,0,1,0,1,0,0,0,0,0
300,CX-5461,"CX5461, CX 5461",RNA Polymerase 1,Other,25257557,513.6,"'N', 'O', 'H', 'C', 'S'",12,0,3.3,0.0,120.0,915.0,1,9,4,37,0,0,0,0,1,C27H27N7O2S,CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C,"InChI=1S/C27H27N7O2S/c1-17-14-29-18(15-28-17)16-30-26(36)23-24(35)19-8-9-22(33-11-5-10-32(2)12-13-33)31-25(19)34-20-6-3-4-7-21(20)37-27(23)34/h3-4,6-9,14-15H,5,10-13,16H2,1-2H3,(H,30,36)",XGPBJCHFROADCK-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
301,PHA-793887,"PHA793887, PHA 793887","CDK2, CDK7, CDK5",Cell cycle,46191454,361.5,"'C', 'N', 'H', 'O'",4,0,1.0,0.0,81.3,542.0,2,4,4,26,0,0,0,0,1,C19H31N5O2,CC(C)CC(=O)NC1=NNC2=C1CN(C2(C)C)C(=O)C3CCN(CC3)C,"InChI=1S/C19H31N5O2/c1-12(2)10-15(25)20-17-14-11-24(19(3,4)16(14)21-22-17)18(26)13-6-8-23(5)9-7-13/h12-13H,6-11H2,1-5H3,(H2,20,21,22,25)",HUXYBQXJVXOMKX-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
302,PI-103,"PI-103, PI103, PI 103","PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2",PI3K/MTOR signaling,9884685,348.4,"'C', 'N', 'H', 'O'",9,0,2.7,0.0,84.5,489.0,1,7,2,26,0,0,0,0,1,C19H16N4O3,C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O,"InChI=1S/C19H16N4O3/c24-13-4-1-3-12(11-13)17-21-15-14-5-2-6-20-19(14)26-16(15)18(22-17)23-7-9-25-10-8-23/h1-6,11,24H,7-10H2",TUVCWJQQGGETHL-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
303,PIK-93,"PIK 93, PIK93",PI3Kgamma,PI3K/MTOR signaling,6852167,389.9,"'N', 'O', 'H', 'C', 'Cl', 'S'",8,0,1.4,0.0,145.0,543.0,3,7,6,24,0,0,0,0,1,C14H16ClN3O4S2,CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO,"InChI=1S/C14H16ClN3O4S2/c1-8-13(23-14(17-8)18-9(2)20)10-3-4-11(15)12(7-10)24(21,22)16-5-6-19/h3-4,7,16,19H,5-6H2,1-2H3,(H,17,18,20)",JFVNFXCESCXMBC-UHFFFAOYSA-N,0,0,1,0,1,0,1,1,0,0
304,SB52334,"SB-52334, SB 52334",ALK5,RTK signaling,9967941,343.4,"'C', 'N', 'H'",10,0,3.7,0.0,67.4,476.0,1,4,3,26,0,0,0,0,1,C21H21N5,CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=NC=CN=C4C=C3,"InChI=1S/C21H21N5/c1-13-6-5-7-16(24-13)19-18(25-20(26-19)21(2,3)4)14-8-9-15-17(12-14)23-11-10-22-15/h5-12H,1-4H3,(H,25,26)",DKPQHFZUICCZHF-UHFFFAOYSA-N,0,0,1,0,0,0,0,0,0,0
305,TPCA-1,-,IKK2,"Other, kinases",9903786,279.29,"'N', 'O', 'H', 'C', 'S', 'F'",7,0,1.7,0.0,126.0,361.0,3,4,3,19,0,0,0,0,1,C12H10FN3O2S,C1=CC(=CC=C1C2=CC(=C(S2)NC(=O)N)C(=O)N)F,"InChI=1S/C12H10FN3O2S/c13-7-3-1-6(2-4-7)9-5-8(10(14)17)11(19-9)16-12(15)18/h1-5H,(H2,14,17)(H3,15,16,18)",SAYGKHKXGCPTLX-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,1,0
306,Fedratinib,"TG101348, TG-101348, SAR302503, SAR-302503",JAK2,"Other, kinases",16722836,524.7,"'N', 'O', 'H', 'C', 'S'",11,0,4.8,0.0,117.0,787.0,3,9,11,37,0,0,0,0,1,C27H36N6O3S,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,"InChI=1S/C27H36N6O3S/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31)",JOOXLOJCABQBSG-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
308,WIKI4,"WIKI-4, WIKI 4","TNKS1, TNKS2",WNT signaling,2984337,521.6,"'N', 'O', 'H', 'C', 'S'",15,0,4.8,0.0,116.0,803.0,0,7,8,38,0,0,0,0,1,C29H23N5O3S,COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6,"InChI=1S/C29H23N5O3S/c1-37-22-11-9-21(10-12-22)34-26(20-13-15-30-16-14-20)31-32-29(34)38-18-4-17-33-27(35)23-7-2-5-19-6-3-8-24(25(19)23)28(33)36/h2-3,5-16H,4,17-18H2,1H3",RNUXIZKXJOGYQP-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
309,Y-39983,-,ROCK,Cytoskeleton,9810884,280.32,"'C', 'N', 'H', 'O'",8,0,1.4,0.0,83.8,367.0,3,3,3,21,1,1,0,0,1,C16H16N4O,CC(C1=CC=C(C=C1)C(=O)NC2=C3C=CNC3=NC=C2)N,"InChI=1S/C16H16N4O/c1-10(17)11-2-4-12(5-3-11)16(21)20-14-7-9-19-15-13(14)6-8-18-15/h2-10H,17H2,1H3,(H2,18,19,20,21)/t10-/m1/s1",JTVBXQAYBIJXRP-SNVBAGLBSA-N,0,0,1,0,1,0,0,0,0,0
310,YM201636,"YM-201636, YM 201636",PYKFYVE,Other,9956222,467.5,"'C', 'N', 'H', 'O'",13,0,2.5,0.0,132.0,738.0,2,9,4,35,0,0,0,0,1,C25H21N7O3,C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N,"InChI=1S/C25H21N7O3/c26-19-7-6-16(14-28-19)24(33)29-17-4-1-3-15(13-17)22-30-20-18-5-2-8-27-25(18)35-21(20)23(31-22)32-9-11-34-12-10-32/h1-8,13-14H,9-12H2,(H2,26,28)(H,29,33)",YBPIBGNBHHGLEB-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
312,Tivozanib,"AV-951, AV 951, KRN-951, KIL8951, ASP-4130","VEGFR1, VEGFR2, VEGFR3",RTK signaling,9911830,454.9,"'N', 'O', 'H', 'C', 'Cl'",11,0,4.0,0.0,108.0,631.0,2,7,6,32,0,0,0,0,1,C22H19ClN4O5,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,"InChI=1S/C22H19ClN4O5/c1-12-8-21(27-32-12)26-22(28)25-16-5-4-13(9-15(16)23)31-18-6-7-24-17-11-20(30-3)19(29-2)10-14(17)18/h4-11H,1-3H3,(H2,25,26,27,28)",SPMVMDHWKHCIDT-UHFFFAOYSA-N,0,0,1,0,1,0,1,0,0,0
326,GSK690693,"GSK 690693, GSK-690693","AKT1, AKT2, AKT3",PI3K/MTOR signaling,16725726,425.5,"'C', 'N', 'H', 'O'",6,1,0.3,0.0,137.0,680.0,3,9,7,31,1,1,0,0,1,C21H27N7O3,CCN1C2=C(C(=NC=C2OCC3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N,"InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-5-9-23-10-13)11-24-14(7-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4-6,9-10,12H2,1-3H3,(H2,22,27)/t13-/m0/s1",KGPGFQWBCSZGEL-ZDUSSCGKSA-N,0,0,1,0,1,0,0,0,0,0
328,SNX-2112,SNX 2112,HSP90,Protein stability and degradation,24772860,464.5,"'N', 'O', 'H', 'C', 'F'",7,0,3.8,0.0,110.0,754.0,3,8,4,33,0,0,0,0,1,C23H27F3N4O3,CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C,"InChI=1S/C23H27F3N4O3/c1-22(2)10-17-19(18(32)11-22)20(23(24,25)26)29-30(17)13-5-8-15(21(27)33)16(9-13)28-12-3-6-14(31)7-4-12/h5,8-9,12,14,28,31H,3-4,6-7,10-11H2,1-2H3,(H2,27,33)",ZFVRYNYOPQZKDG-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
329,QL-XI-92,-,DDR1,Other,73265214,458.4,"'N', 'O', 'H', 'C', 'F'",12,0,3.4,0.0,113.0,748.0,3,8,6,33,0,0,0,0,1,C22H17F3N4O4,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)NC(=O)C=C)C(F)(F)F)NC(=O)C3=CC=NO3,"InChI=1S/C22H17F3N4O4/c1-3-19(30)27-15-9-14(22(23,24)25)10-16(11-15)28-20(31)13-5-4-12(2)17(8-13)29-21(32)18-6-7-26-33-18/h3-11H,1H2,2H3,(H,27,30)(H,28,31)(H,29,32)",UASQUKUDXJFTCO-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
331,QL-X-138,-,BTK,"Other, kinases",73707530,421.4,"'C', 'N', 'H', 'O'",14,0,3.4,0.0,91.0,769.0,2,4,4,32,0,0,0,0,1,C25H19N5O2,CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C,"InChI=1S/C25H19N5O2/c1-3-23(31)29-22-11-19(7-4-15(22)2)30-24(32)9-6-17-12-26-21-8-5-16(10-20(21)25(17)30)18-13-27-28-14-18/h3-14H,1H2,2H3,(H,27,28)(H,29,31)",JMVDIGHUQAXWIE-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
333,T0901317,"TO-901317, TO901317","LXR, FXR",Other,447912,481.3,"'N', 'O', 'H', 'C', 'S', 'F'",8,0,4.9,0.0,66.0,684.0,1,13,5,31,0,0,0,0,1,C17H12F9NO3S,C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O,"InChI=1S/C17H12F9NO3S/c18-14(19,20)10-27(31(29,30)13-4-2-1-3-5-13)12-8-6-11(7-9-12)15(28,16(21,22)23)17(24,25)26/h1-9,28H,10H2",SGIWFELWJPNFDH-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,1,0
341,Selisistat,"EX-527, EX 527",SIRT1,Chromatin histone acetylation,5113032,248.71,"'N', 'O', 'H', 'C', 'Cl'",5,0,2.5,0.0,58.9,323.0,2,1,1,17,1,0,1,0,1,C13H13ClN2O,C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N,"InChI=1S/C13H13ClN2O/c14-7-4-5-11-10(6-7)8-2-1-3-9(13(15)17)12(8)16-11/h4-6,9,16H,1-3H2,(H2,15,17)",FUZYTVDVLBBXDL-UHFFFAOYSA-N,0,0,1,0,1,0,1,0,0,0
344,THZ-2-49,-,CDK9,Cell cycle,78357763,566.1,"'N', 'O', 'H', 'C', 'Cl'",16,0,4.8,0.0,115.0,904.0,4,6,9,41,0,0,0,1,1,C31H28ClN7O2,CN(C)CC=CC(=O)NC1=CC=CC(=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl,"InChI=1S/C31H28ClN7O2/c1-39(2)15-7-14-28(40)35-21-9-5-8-20(16-21)30(41)36-22-10-6-11-23(17-22)37-31-34-19-26(32)29(38-31)25-18-33-27-13-4-3-12-24(25)27/h3-14,16-19,33H,15H2,1-2H3,(H,35,40)(H,36,41)(H,34,37,38)/b14-7+",FONRCZUZCHXWBD-VGOFMYFVSA-N,0,0,1,0,1,0,1,0,0,0
345,KIN001-270,"CDK9 inhibitor, CDK9-IN-1",CDK9,Cell cycle,66577006,499.5,"'N', 'O', 'H', 'C', 'S'",16,0,3.6,0.0,130.0,900.0,2,8,6,36,0,0,0,0,1,C26H21N5O4S,CC1=C(C=C(C=C1)NC2=NC=NC(=C2)C3=CC(=CC=C3)N4C(=O)C5=CC=CC=C5C4=O)NS(=O)(=O)C,"InChI=1S/C26H21N5O4S/c1-16-10-11-18(13-22(16)30-36(2,34)35)29-24-14-23(27-15-28-24)17-6-5-7-19(12-17)31-25(32)20-8-3-4-9-21(20)26(31)33/h3-15,30H,1-2H3,(H,27,28,29)",CKUFOBCNTCLXJP-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
346,THZ-2-102-1,-,CDK7,Cell cycle,146011539,553.0,"'N', 'O', 'H', 'C', 'Cl', 'F'",9,0,8.0,0.0,96.7,870.0,2,9,5,38,2,2,0,0,1,C26H28ClF3N4O4,CC1CC(CC(C1)(C)C)N2C3=C(C=C(C(=C3)Cl)C(=O)N(C)C(=O)O)N=C2NC4=CC=C(C=C4)OC(F)(F)F,"InChI=1S/C26H28ClF3N4O4/c1-14-9-16(13-25(2,3)12-14)34-21-11-19(27)18(22(35)33(4)24(36)37)10-20(21)32-23(34)31-15-5-7-17(8-6-15)38-26(28,29)30/h5-8,10-11,14,16H,9,12-13H2,1-4H3,(H,31,32)(H,36,37)/t14-,16+/m1/s1",RZINNNPVGBOLQA-ZBFHGGJFSA-N,0,0,1,0,1,0,1,0,1,0
1001,AICA Ribonucleotide,"AICAR, N1-(b-D-Ribofuranosyl)-5-aminoimidazole-4-carboxamide",AMPK agonist,Metabolism,65110,338.21,"'N', 'O', 'H', 'C', 'P'",4,0,-3.8,0.0,203.0,475.0,6,10,5,22,4,4,0,0,1,C9H15N4O8P,C1=NC(=C(N1C2C(C(C(O2)COP(=O)(O)O)O)O)N)C(=O)N,"InChI=1S/C9H15N4O8P/c10-7-4(8(11)16)12-2-13(7)9-6(15)5(14)3(21-9)1-20-22(17,18)19/h2-3,5-6,9,14-15H,1,10H2,(H2,11,16)(H2,17,18,19)/t3-,5-,6-,9-/m1/s1",NOTGFIUVDGNKRI-UUOKFMHZSA-N,0,0,1,0,1,0,0,0,0,1
1003,Camptothecin,"7-Ethyl-10-Hydroxy-Camptothecin, SN-38, Irinotecan, Camptothecin-11, Camptosar",TOP1,DNA replication,24360,348.4,"'C', 'N', 'H', 'O'",9,0,1.0,0.0,79.7,742.0,1,5,1,26,1,1,0,0,1,C20H16N2O4,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O,"InChI=1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1",VSJKWCGYPAHWDS-FQEVSTJZSA-N,0,0,1,0,1,0,0,0,0,0
1004,Vinblastine,Velban,Microtubule destabiliser,Mitosis,6710780,811.0,"'C', 'N', 'H', 'O'",11,0,3.7,0.0,154.0,1700.0,3,12,10,59,9,8,1,0,1,C46H58N4O9,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,"InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28?,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1",JXLYSJRDGCGARV-CUGARIAGSA-N,0,0,1,0,1,0,0,0,0,0
1005,Cisplatin,"cis-Diammineplatinum(II) dichloride, Platinol, CIS-DDP",DNA crosslinker,DNA replication,84691,300.0,"'Pt', 'N', 'H', 'Cl'",0,0,,0.0,2.0,0.0,2,4,0,5,0,0,0,0,5,Cl2H6N2Pt,N.N.[Cl-].[Cl-].[Pt+2],InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2,LXZZYRPGZAFOLE-UHFFFAOYSA-L,1,0,1,0,0,0,1,0,0,1
1006,Cytarabine,"Ara-Cytidine, Arabinosyl Cytosine, U-19920",Antimetabolite,DNA replication,6253,243.22,"'C', 'N', 'H', 'O'",3,0,-2.1,0.0,129.0,383.0,4,5,2,17,4,4,0,0,1,C9H13N3O5,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,"InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1",UHDGCWIWMRVCDJ-CCXZUQQUSA-N,0,0,1,0,1,0,0,0,0,0
1007,Docetaxel,"RP-56976, Taxotere",Microtubule stabiliser,Mitosis,148124,807.9,"'C', 'N', 'H', 'O'",12,0,1.6,0.0,224.0,1660.0,5,14,13,58,11,11,0,0,1,C43H53NO14,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,"InChI=1S/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,52)/t26-,27-,28+,30-,31+,32+,33-,35-,41+,42-,43+/m0/s1",ZDZOTLJHXYCWBA-VCVYQWHSSA-N,0,0,1,0,1,0,0,0,0,0
1008,Methotrexate,"Abitrexate, Amethopterin, Rheumatrex, Trexall, Folex",Antimetabolite,DNA replication,126941,454.4,"'C', 'N', 'H', 'O'",11,0,-1.8,0.0,211.0,704.0,5,12,9,33,1,1,0,0,1,C20H22N8O5,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,"InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1",FBOZXECLQNJBKD-ZDUSSCGKSA-N,0,0,1,0,1,0,0,0,0,0
1009,Tretinoin,"ATRA, Vesanoid, Renova, Atralin, Tretin-X, Avita",Retinoic acid,Other,444795,300.4,"'C', 'H', 'O'",6,0,6.3,0.0,37.3,567.0,1,2,5,22,0,0,0,4,1,C20H28O2,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+",SHGAZHPCJJPHSC-YCNIQYBTSA-N,0,0,0,0,1,0,0,0,0,0
1010,Gefitinib,"ZD-1839, Iressa",EGFR,EGFR signaling,123631,446.9,"'N', 'O', 'H', 'C', 'Cl', 'F'",8,0,4.1,0.0,68.7,545.0,1,8,8,31,0,0,0,0,1,C22H24ClFN4O3,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,"InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)",XGALLCVXEZPNRQ-UHFFFAOYSA-N,0,0,1,0,1,0,1,0,1,0
1011,Navitoclax,"ABT-263, ABT263, ABT 263","BCL2, BCL-XL, BCL-W",Apoptosis regulation,24978538,974.6,"'N', 'O', 'H', 'C', 'Cl', 'S', 'F'",18,0,9.6,0.0,170.0,1800.0,2,14,16,65,1,1,0,0,1,C47H55ClF3N5O6S3,CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)NC(CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C,"InChI=1S/C47H55ClF3N5O6S3/c1-46(2)20-18-42(34-8-12-37(48)13-9-34)36(31-46)32-55-22-24-56(25-23-55)39-14-10-35(11-15-39)45(57)53-65(60,61)41-16-17-43(44(30-41)64(58,59)47(49,50)51)52-38(19-21-54-26-28-62-29-27-54)33-63-40-6-4-3-5-7-40/h3-17,30,38,52H,18-29,31-33H2,1-2H3,(H,53,57)/t38-/m1/s1",JLYAXFNOILIKPP-KXQOOQHDSA-N,0,0,1,0,1,0,1,1,1,0
1012,Vorinostat,"Zolinza, SAHA, suberanilohydroxamic acid, suberoylanilide hydroxamic acid, MK-0683","HDAC inhibitor Class I, IIa, IIb, IV",Chromatin histone acetylation,5311,264.32,"'C', 'N', 'H', 'O'",5,0,1.9,0.0,78.4,276.0,3,3,8,19,0,0,0,0,1,C14H20N2O3,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,"InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)",WAEXFXRVDQXREF-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1013,Nilotinib,"Tasigna, AMN 107",ABL,ABL signaling,644241,529.5,"'N', 'O', 'H', 'C', 'F'",15,0,4.9,0.0,97.6,817.0,2,9,6,39,0,0,0,0,1,C28H22F3N7O,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,"InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37)",HHZIURLSWUIHRB-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
1014,Refametinib,"RDEA119, BAY-86-9766, BAY 869766","MEK1, MEK2",ERK MAPK signaling,44182295,572.3,"'I', 'N', 'O', 'H', 'C', 'S', 'F'",8,0,2.8,0.0,116.0,711.0,4,10,9,31,1,1,0,0,1,C19H20F3IN2O5S,COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)CC(CO)O)NC3=C(C=C(C=C3)I)F)F)F,"InChI=1S/C19H20F3IN2O5S/c1-30-15-7-13(21)16(22)18(24-14-3-2-10(23)6-12(14)20)17(15)25-31(28,29)19(4-5-19)8-11(27)9-26/h2-3,6-7,11,24-27H,4-5,8-9H2,1H3/t11-/m0/s1",RDSACQWTXKSHJT-NSHDSACASA-N,0,0,1,1,1,0,0,1,1,0
1015,CI-1040,"CI 1040, PD-18435, PD-184352, 212631-79-3","MEK1, MEK2",ERK MAPK signaling,6918454,478.7,"'I', 'N', 'O', 'H', 'C', 'Cl', 'F'",7,0,5.6,0.0,50.4,472.0,2,5,6,25,0,0,0,0,1,C17H14ClF2IN2O2,C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl,"InChI=1S/C17H14ClF2IN2O2/c18-12-7-10(21)3-6-14(12)22-16-11(4-5-13(19)15(16)20)17(24)23-25-8-9-1-2-9/h3-7,9,22H,1-2,8H2,(H,23,24)",GFMMXOIFOQCCGU-UHFFFAOYSA-N,0,0,1,1,1,0,1,0,1,0
1016,Temsirolimus,"CCI-779, Torisel",MTOR,PI3K/MTOR signaling,6918289,1030.3,"'C', 'N', 'H', 'O'",10,0,5.6,0.0,242.0,2010.0,4,16,11,73,15,15,0,4,1,C56H87NO16,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,"InChI=1S/C56H87NO16/c1-33-17-13-12-14-18-34(2)45(68-9)29-41-22-20-39(7)56(67,73-41)51(63)52(64)57-24-16-15-19-42(57)53(65)71-46(30-43(60)35(3)26-38(6)49(62)50(70-11)48(61)37(5)25-33)36(4)27-40-21-23-44(47(28-40)69-10)72-54(66)55(8,31-58)32-59/h12-14,17-18,26,33,35-37,39-42,44-47,49-50,58-59,62,67H,15-16,19-25,27-32H2,1-11H3/b14-12+,17-13+,34-18+,38-26+/t33-,35-,36-,37-,39-,40+,41+,42+,44-,45+,46+,47-,49-,50+,56-/m1/s1",CBPNZQVSJQDFBE-FUXHJELOSA-N,0,0,1,0,1,0,0,0,0,0
1017,Olaparib,"AZD2281, KU0059436,  Lynparza","PARP1, PARP2",Genome integrity,23725625,434.5,"'N', 'O', 'H', 'C', 'F'",10,0,1.9,0.0,82.1,790.0,1,5,4,32,0,0,0,0,1,C24H23FN4O3,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,"InChI=1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30)",FDLYAMZZIXQODN-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
1018,Veliparib,"ABT-888, ABT888, ABT 888","PARP1, PARP2",Genome integrity,11960529,244.29,"'C', 'N', 'H', 'O'",5,0,0.5,0.0,83.8,348.0,3,3,2,18,1,1,0,0,1,C13H16N4O,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,"InChI=1S/C13H16N4O/c1-13(6-3-7-15-13)12-16-9-5-2-4-8(11(14)18)10(9)17-12/h2,4-5,15H,3,6-7H2,1H3,(H2,14,18)(H,16,17)/t13-/m1/s1",JNAHVYVRKWKWKQ-CYBMUJFWSA-N,0,0,1,0,1,0,0,0,0,0
1019,Bosutinib,"SKI-606, Bosulif","SRC, ABL, TEC","Other, kinases",5328940,530.4,"'N', 'O', 'H', 'C', 'Cl'",8,1,5.4,0.0,82.9,734.0,1,8,9,36,0,0,0,0,1,C26H29Cl2N5O3,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,"InChI=1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31)",UBPYILGKFZZVDX-UHFFFAOYSA-N,0,0,1,0,1,0,1,0,0,0
1020,Lenalidomide,"CDC-501, CC-5013, Revlimid",CRBN,Protein stability and degradation,216326,259.26,"'C', 'N', 'H', 'O'",6,0,-0.5,0.0,92.5,437.0,2,4,1,19,1,0,1,0,1,C13H13N3O3,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,"InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)",GOTYRUGSSMKFNF-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1021,Axitinib,"AG-13736, Inlyta","PDGFR, KIT, VEGFR",RTK signaling,6450551,386.5,"'N', 'O', 'H', 'C', 'S'",12,0,4.2,0.0,96.0,557.0,2,4,5,28,0,0,0,1,1,C22H18N4OS,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,"InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+",RITAVMQDGBJQJZ-FMIVXFBMSA-N,0,0,1,0,1,0,0,1,0,0
1022,AZD7762,"AZD-7762, AZD 7762","CHEK1, CHEK2",Cell cycle,11152667,362.4,"'N', 'O', 'H', 'C', 'S', 'F'",7,0,2.3,0.0,125.0,495.0,4,5,4,25,1,1,0,0,1,C17H19FN4O2S,C1CC(CNC1)NC(=O)C2=C(C=C(S2)C3=CC(=CC=C3)F)NC(=O)N,"InChI=1S/C17H19FN4O2S/c18-11-4-1-3-10(7-11)14-8-13(22-17(19)24)15(25-14)16(23)21-12-5-2-6-20-9-12/h1,3-4,7-8,12,20H,2,5-6,9H2,(H,21,23)(H3,19,22,24)/t12-/m0/s1",IAYGCINLNONXHY-LBPRGKRZSA-N,0,0,1,0,1,0,0,1,1,0
1023,GW441756,GW 441756,NTRK1,RTK signaling,9943465,275.3,"'C', 'N', 'H', 'O'",9,0,1.9,0.0,46.9,461.0,1,2,1,21,0,0,0,1,1,C17H13N3O,CN1C=C(C2=CC=CC=C21)C=C3C4=C(C=CC=N4)NC3=O,"InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)/b13-9-",NXNQLECPAXXYTR-LCYFTJDESA-N,0,0,1,0,1,0,0,0,0,0
1024,Lestauritinib,"CEP-701, SP-924, SPM-924, A-154475, KT-555","FLT3, JAK2, NTRK1, NTRK2, NTRK3","Other, kinases",126565,439.5,"'C', 'N', 'H', 'O'",10,0,2.2,0.0,88.6,886.0,3,4,1,33,3,3,0,0,1,C26H21N3O4,CC12C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O,"InChI=1S/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18-,25+,26+/m1/s1",UIARLYUEJFELEN-LROUJFHJSA-N,0,0,1,0,1,0,0,0,0,0
1025,SB216763,"SB-216763, SB 216763","GSK3A, GSK3B",WNT signaling,176158,371.2,"'N', 'O', 'H', 'C', 'Cl'",10,0,3.9,0.0,51.1,621.0,1,2,2,25,0,0,0,0,1,C19H12Cl2N2O2,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C(C=C(C=C4)Cl)Cl,"InChI=1S/C19H12Cl2N2O2/c1-23-9-13(11-4-2-3-5-15(11)23)17-16(18(24)22-19(17)25)12-7-6-10(20)8-14(12)21/h2-9H,1H3,(H,22,24,25)",JCSGFHVFHSKIJH-UHFFFAOYSA-N,0,0,1,0,1,0,1,0,0,0
1026,Tanespimycin,"17-AAG, BMS-722782",HSP90,Protein stability and degradation,6505803,585.7,"'C', 'N', 'H', 'O'",10,0,2.6,0.0,166.0,1210.0,4,9,7,42,6,6,0,3,1,C31H43N3O8,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC,"InChI=1S/C31H43N3O8/c1-8-12-33-26-21-13-17(2)14-25(41-7)27(36)19(4)15-20(5)29(42-31(32)39)24(40-6)11-9-10-18(3)30(38)34-22(28(21)37)16-23(26)35/h8-11,15-17,19,24-25,27,29,33,36H,1,12-14H2,2-7H3,(H2,32,39)(H,34,38)/b11-9-,18-10+,20-15+/t17-,19+,24+,25+,27-,29+/m1/s1",AYUNIORJHRXIBJ-TXHRRWQRSA-N,0,0,1,0,1,0,0,0,0,0
1028,VX-702,"VX702, VX 702",p38,JNK and p38 signaling,10341154,404.3,"'N', 'O', 'H', 'C', 'F'",11,0,2.5,0.0,102.0,603.0,2,7,4,29,0,0,0,0,1,C19H12F4N4O2,C1=CC(=C(C(=C1)F)N(C2=NC(=C(C=C2)C(=O)N)C3=C(C=C(C=C3)F)F)C(=O)N)F,"InChI=1S/C19H12F4N4O2/c20-9-4-5-10(14(23)8-9)16-11(18(24)28)6-7-15(26-16)27(19(25)29)17-12(21)2-1-3-13(17)22/h1-8H,(H2,24,28)(H2,25,29)",FYSRKRZDBHOFAY-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
1029,Motesanib,"AMG-706, AMG 706, AMG706","VEGFR, RET, KIT, PDGFR",RTK signaling,11667893,373.5,"'C', 'N', 'H', 'O'",10,0,3.9,0.0,78.9,533.0,3,5,5,28,0,0,0,0,1,C22H23N5O,CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C,"InChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28)",RAHBGWKEPAQNFF-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1030,KU-55933,KU55933,ATM,Genome integrity,5278396,395.5,"'N', 'O', 'H', 'C', 'S'",9,0,3.9,0.0,89.4,643.0,0,6,2,27,0,0,0,0,1,C21H17NO3S2,C1COCCN1C2=CC(=O)C=C(O2)C3=C4C(=CC=C3)SC5=CC=CC=C5S4,"InChI=1S/C21H17NO3S2/c23-14-12-16(25-20(13-14)22-8-10-24-11-9-22)15-4-3-7-19-21(15)27-18-6-2-1-5-17(18)26-19/h1-7,12-13H,8-11H2",XRKYMMUGXMWDAO-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
1031,Elesclomol,STA-4783,HSP90,Protein stability and degradation,300471,400.5,"'N', 'O', 'H', 'C', 'S'",10,0,2.9,0.0,129.0,510.0,2,4,4,27,0,0,0,0,1,C19H20N4O2S2,CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2,"InChI=1S/C19H20N4O2S2/c1-22(18(26)14-9-5-3-6-10-14)20-16(24)13-17(25)21-23(2)19(27)15-11-7-4-8-12-15/h3-12H,13H2,1-2H3,(H,20,24)(H,21,25)",BKJIXTWSNXCKJH-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
1032,Afatinib,"BIBW2992, Tovok, Gilotrif","ERBB2, EGFR",EGFR signaling,10184653,485.9,"'N', 'O', 'H', 'C', 'Cl', 'F'",10,0,3.6,0.0,88.6,702.0,2,8,8,34,1,1,0,1,1,C24H25ClFN5O3,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,"InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1",ULXXDDBFHOBEHA-CWDCEQMOSA-N,0,0,1,0,1,0,1,0,1,0
1033,Vismodegib,"GDC0449, Erivedge",SMO,Other,24776445,421.3,"'N', 'O', 'H', 'C', 'Cl', 'S'",12,0,3.8,0.0,84.5,625.0,1,4,4,27,0,0,0,0,1,C19H14Cl2N2O3S,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,"InChI=1S/C19H14Cl2N2O3S/c1-27(25,26)13-6-7-14(17(21)11-13)19(24)23-12-5-8-16(20)15(10-12)18-4-2-3-9-22-18/h2-11H,1H3,(H,23,24)",BPQMGSKTAYIVFO-UHFFFAOYSA-N,0,0,1,0,1,0,1,1,0,0
1036,PLX-4720,"PLX4720, PLX 4720",BRAF,ERK MAPK signaling,24180719,413.8,"'N', 'O', 'H', 'C', 'Cl', 'S', 'F'",10,0,3.3,0.0,100.0,648.0,2,7,6,27,0,0,0,0,1,C17H14ClF2N3O3S,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)Cl)F,"InChI=1S/C17H14ClF2N3O3S/c1-2-5-27(25,26)23-13-4-3-12(19)14(15(13)20)16(24)11-8-22-17-10(11)6-9(18)7-21-17/h3-4,6-8,23H,2,5H2,1H3,(H,21,22)",YZDJQTHVDDOVHR-UHFFFAOYSA-N,0,0,1,0,1,0,1,1,1,0
1038,NU7441,"KU-57788, NU-7432, NU-7741",DNAPK,Genome integrity,11327430,413.5,"'N', 'O', 'H', 'C', 'S'",11,0,5.5,0.0,67.0,690.0,0,5,2,30,0,0,0,0,1,C25H19NO3S,C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC5=C4SC6=CC=CC=C56,"InChI=1S/C25H19NO3S/c27-21-15-23(26-11-13-28-14-12-26)29-24-17(6-3-9-20(21)24)19-8-4-7-18-16-5-1-2-10-22(16)30-25(18)19/h1-10,15H,11-14H2",JAMULYFATHSZJM-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
1039,SL0101,"SL-0101, SL 0101-1","RSK, AURKB, PIM1, PIM3",Other,10459196,516.4,"'C', 'H', 'O'",10,0,2.4,0.0,178.0,909.0,4,12,7,37,5,5,0,0,1,C25H24O12,CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)OC(=O)C)OC(=O)C,"InChI=1S/C25H24O12/c1-10-21(34-11(2)26)24(35-12(3)27)20(32)25(33-10)37-23-19(31)18-16(30)8-15(29)9-17(18)36-22(23)13-4-6-14(28)7-5-13/h4-10,20-21,24-25,28-30,32H,1-3H3/t10-,20+,21-,24-,25-/m0/s1",SXOZSDJHGMAEGZ-IGKKHSBFSA-N,0,0,0,0,1,0,0,0,0,0
1042,Doramapimod,"BIRB-796, BIRB 796","p38, JNK2",JNK and p38 signaling,156422,527.7,"'C', 'N', 'H', 'O'",11,0,5.7,0.0,80.6,777.0,2,5,8,39,0,0,0,0,1,C31H37N5O3,CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5,"InChI=1S/C31H37N5O3/c1-22-9-11-23(12-10-22)36-29(21-28(34-36)31(2,3)4)33-30(37)32-26-13-14-27(25-8-6-5-7-24(25)26)39-20-17-35-15-18-38-19-16-35/h5-14,21H,15-20H2,1-4H3,(H2,32,33,37)",MVCOAUNKQVWQHZ-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1043,JNK Inhibitor VIII,-,JNK,JNK and p38 signaling,11624601,356.4,"'C', 'N', 'H', 'O'",7,1,2.2,0.0,120.0,509.0,2,7,7,26,0,0,0,0,1,C18H20N4O4,CCOC1=C(C(=CC(=N1)NC(=O)CC2=C(C=CC(=C2)OC)OC)N)C#N,"InChI=1S/C18H20N4O4/c1-4-26-18-13(10-19)14(20)9-16(22-18)21-17(23)8-11-7-12(24-2)5-6-15(11)25-3/h5-7,9H,4,8H2,1-3H3,(H3,20,21,22,23)",KQMPRSZTUSSXND-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1046,681640,-,"WEE1, CHEK1",Cell cycle,10384072,362.8,"'N', 'O', 'H', 'C', 'Cl'",11,0,4.1,0.0,82.2,614.0,3,3,1,26,0,0,0,0,1,C20H11ClN2O3,C1=CC=C(C(=C1)C2=CC3=C(C4=C(N3)C=CC(=C4)O)C5=C2C(=O)NC5=O)Cl,"InChI=1S/C20H11ClN2O3/c21-13-4-2-1-3-10(13)11-8-15-16(18-17(11)19(25)23-20(18)26)12-7-9(24)5-6-14(12)22-15/h1-8,22,24H,(H,23,25,26)",DPEXRCOBPACFOO-UHFFFAOYSA-N,0,0,1,0,1,0,1,0,0,0
1047,Nutlin-3a (-),-,MDM2,p53 pathway,11433190,581.5,"'N', 'O', 'H', 'C', 'Cl'",12,0,5.2,0.0,83.5,919.0,1,5,6,40,2,2,0,0,1,C30H30Cl2N4O4,CC(C)OC1=C(C=CC(=C1)OC)C2=NC(C(N2C(=O)N3CCNC(=O)C3)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl,"InChI=1S/C30H30Cl2N4O4/c1-18(2)40-25-16-23(39-3)12-13-24(25)29-34-27(19-4-8-21(31)9-5-19)28(20-6-10-22(32)11-7-20)36(29)30(38)35-15-14-33-26(37)17-35/h4-13,16,18,27-28H,14-15,17H2,1-3H3,(H,33,37)/t27-,28+/m0/s1",BDUHCSBCVGXTJM-WUFINQPMSA-N,0,0,1,0,1,0,1,0,0,0
1049,PD173074,"PD-173074, PD 173074","FGFR1, FGFR3",RTK signaling,1401,523.7,"'C', 'N', 'H', 'O'",9,0,4.5,0.0,114.0,690.0,3,8,13,38,0,0,0,0,1,C28H41N7O3,CCN(CC)CCCCNC1=NC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C,"InChI=1S/C28H41N7O3/c1-8-35(9-2)13-11-10-12-29-26-30-18-20-16-23(19-14-21(37-6)17-22(15-19)38-7)25(31-24(20)32-26)33-27(36)34-28(3,4)5/h14-18H,8-13H2,1-7H3,(H3,29,30,31,32,33,34,36)",DXCUKNQANPLTEJ-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1050,ZM447439,"ZM-447439, ZM 447439","AURKA, AURKB",Mitosis,9914412,513.6,"'C', 'N', 'H', 'O'",12,0,4.2,0.0,97.8,709.0,2,8,10,38,0,0,0,0,1,C29H31N5O4,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5,"InChI=1S/C29H31N5O4/c1-36-26-18-24-25(19-27(26)38-15-5-12-34-13-16-37-17-14-34)30-20-31-28(24)32-22-8-10-23(11-9-22)33-29(35)21-6-3-2-4-7-21/h2-4,6-11,18-20H,5,12-17H2,1H3,(H,33,35)(H,30,31,32)",OGNYUTNQZVRGMN-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1052,RO-3306,-,CDK1,Cell cycle,44450571,351.4,"'N', 'O', 'H', 'C', 'S'",10,0,3.8,0.0,108.0,548.0,1,4,4,24,0,0,0,1,1,C18H13N3OS2,C1=CC2=C(C=CC(=C2)C=C3C(=O)N=C(S3)NCC4=CC=CS4)N=C1,"InChI=1S/C18H13N3OS2/c22-17-16(24-18(21-17)20-11-14-4-2-8-23-14)10-12-5-6-15-13(9-12)3-1-7-19-15/h1-10H,11H2,(H,20,21,22)/b16-10+",XOLMRFUGOINFDQ-MHWRWJLKSA-N,0,0,1,0,1,0,0,1,0,0
1053,MK-2206,"MK 2206, MK2206","AKT1, AKT2",PI3K/MTOR signaling,46930998,480.4,"'N', 'O', 'H', 'C', 'Cl'",12,0,,0.0,83.6,760.0,4,4,3,33,0,0,0,0,3,C25H23Cl2N5O,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N.Cl.Cl,"InChI=1S/C25H21N5O.2ClH/c26-25(12-4-13-25)18-9-7-17(8-10-18)22-19(16-5-2-1-3-6-16)15-20-21(27-22)11-14-30-23(20)28-29-24(30)31;;/h1-3,5-11,14-15H,4,12-13,26H2,(H,29,31);2*1H",HWUHTJIKQZZBRA-UHFFFAOYSA-N,0,0,1,0,1,0,1,0,0,0
1054,Palbociclib,"PD0332991, PD-0332991, PF-00080665-73","CDK4, CDK6",Cell cycle,5330286,447.5,"'C', 'N', 'H', 'O'",9,0,1.8,0.0,103.0,775.0,2,8,5,33,0,0,0,0,1,C24H29N7O2,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,"InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)",AHJRHEGDXFFMBM-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1057,Dactolisib,"NVP-BEZ235, BEZ235","PI3K (Class 1), MTORC1, MTORC2",PI3K/MTOR signaling,11977753,469.5,"'C', 'N', 'H', 'O'",14,1,5.2,0.0,73.1,872.0,0,4,3,36,0,0,0,0,1,C30H23N5O,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,"InChI=1S/C30H23N5O/c1-30(2,18-31)22-9-11-23(12-10-22)35-28-24-15-19(21-14-20-6-4-5-7-25(20)32-16-21)8-13-26(24)33-17-27(28)34(3)29(35)36/h4-17H,1-3H3",JOGKUKXHTYWRGZ-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1058,Pictilisib,"GDC-0941, GDC0941, RG-7621",PI3K (class 1),PI3K/MTOR signaling,17755052,513.6,"'N', 'O', 'H', 'C', 'S'",10,0,1.6,0.0,144.0,832.0,1,10,5,35,0,0,0,0,1,C23H27N7O3S2,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,"InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27)",LHNIIDJUOCFXAP-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
1059,AZD8055,AZD-8055,"MTORC1, MTORC2",PI3K/MTOR signaling,25262965,465.5,"'C', 'N', 'H', 'O'",8,0,2.6,0.0,93.1,659.0,1,9,5,34,2,2,0,0,1,C25H31N5O4,CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOCC5C,"InChI=1S/C25H31N5O4/c1-16-14-33-10-8-29(16)24-20-5-6-21(18-4-7-22(32-3)19(12-18)13-31)26-23(20)27-25(28-24)30-9-11-34-15-17(30)2/h4-7,12,16-17,31H,8-11,13-15H2,1-3H3/t16-,17-/m0/s1",KVLFRAWTRWDEDF-IRXDYDNUSA-N,0,0,1,0,1,0,0,0,0,0
1060,PD0325901,"PD-0325901, PD 0325901","MEK1, MEK2",ERK MAPK signaling,9826528,482.19,"'I', 'N', 'O', 'H', 'C', 'F'",7,0,3.0,0.0,90.8,465.0,4,8,7,26,1,1,0,0,1,C16H14F3IN2O4,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,"InChI=1S/C16H14F3IN2O4/c17-11-3-2-10(16(25)22-26-7-9(24)6-23)15(14(11)19)21-13-4-1-8(20)5-12(13)18/h1-5,9,21,23-24H,6-7H2,(H,22,25)/t9-/m1/s1",SUDAHWBOROXANE-SECBINFHSA-N,0,0,1,1,1,0,0,0,1,0
1061,SB590885,SB-590885,BRAF,ERK MAPK signaling,11316960,453.5,"'C', 'N', 'H', 'O'",12,0,2.1,0.0,78.3,1080.0,2,6,5,34,0,0,0,1,1,C27H27N5O2,CN(C)CCOC1=CC=C(C=C1)C2=NC(=C3C=CC4=C(CCC4=C3)N=O)C(=C5C=CNC=C5)N2,"InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,28H,6,10,15-16H2,1-2H3,(H,29,30)/b26-21-",DPCXEUSDRQOOGZ-QLYXXIJNSA-N,0,0,1,0,1,0,0,0,0,0
1062,Selumetinib,"AZD6244, AZD-6244, ARRY-886","MEK1, MEK2",ERK MAPK signaling,10127622,457.7,"'Br', 'N', 'O', 'H', 'C', 'Cl', 'F'",8,0,3.6,0.0,88.4,523.0,3,6,6,27,0,0,0,0,1,C17H15BrClFN4O3,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,"InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)",CYOHGALHFOKKQC-UHFFFAOYSA-N,0,1,1,0,1,1,1,0,1,0
1066,AZD6482,"AZD 6482, AZD-6482, AK-55409",PI3Kbeta,PI3K/MTOR signaling,44137675,408.4,"'C', 'N', 'H', 'O'",9,0,2.0,0.0,94.5,838.0,2,7,5,30,1,1,0,0,1,C22H24N4O4,CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3C(=O)O)N4CCOCC4,"InChI=1S/C22H24N4O4/c1-14-11-17(15(2)23-18-6-4-3-5-16(18)22(28)29)21-24-19(12-20(27)26(21)13-14)25-7-9-30-10-8-25/h3-6,11-13,15,23H,7-10H2,1-2H3,(H,28,29)/t15-/m1/s1",IRTDIKMSKMREGO-OAHLLOKOSA-N,0,0,1,0,1,0,0,0,0,0
1067,CCT007093,-,PPM1D,Other,2314623,272.4,"'C', 'S', 'H', 'O'",7,0,4.0,0.0,73.6,361.0,0,3,2,18,0,0,0,2,1,C15H12OS2,C1CC(=CC2=CC=CS2)C(=O)C1=CC3=CC=CS3,"InChI=1S/C15H12OS2/c16-15-11(9-13-3-1-7-17-13)5-6-12(15)10-14-4-2-8-18-14/h1-4,7-10H,5-6H2/b11-9+,12-10+",KPFZCKDPBMGECB-WGDLNXRISA-N,0,0,0,0,1,0,0,1,0,0
1069,EHT-1864,EHT 1864,"RAC1, RAC2, RAC3",Cytoskeleton,9938202,581.5,"'N', 'O', 'H', 'C', 'Cl', 'S', 'F'",8,0,,0.0,86.2,770.0,2,10,10,37,0,0,0,0,3,C25H29Cl2F3N2O4S,C1COCCN1CC2=CC(=O)C(=CO2)OCCCCCSC3=C4C=CC(=CC4=NC=C3)C(F)(F)F.Cl.Cl,"InChI=1S/C25H27F3N2O4S.2ClH/c26-25(27,28)18-4-5-20-21(14-18)29-7-6-24(20)35-13-3-1-2-10-33-23-17-34-19(15-22(23)31)16-30-8-11-32-12-9-30;;/h4-7,14-15,17H,1-3,8-13,16H2;2*1H",LSECOAJFCKFQJG-UHFFFAOYSA-N,0,0,1,0,1,0,1,1,1,0
1072,Avagacestat,"BMS-708163, BMS 708163","Amyloid beta20, Amyloid beta40",Other,46883536,520.9,"'N', 'O', 'H', 'C', 'Cl', 'S', 'F'",11,0,4.0,0.0,128.0,792.0,1,11,9,34,1,1,0,0,1,C20H17ClF4N4O4S,C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)C(CCC(F)(F)F)C(=O)N)Cl,"InChI=1S/C20H17ClF4N4O4S/c21-14-3-5-15(6-4-14)34(31,32)29(17(18(26)30)7-8-20(23,24)25)10-13-2-1-12(9-16(13)22)19-27-11-33-28-19/h1-6,9,11,17H,7-8,10H2,(H2,26,30)/t17-/m1/s1",XEAOPVUAMONVLA-QGZVFWFLSA-N,0,0,1,0,1,0,1,1,1,0
1091,BMS-536924,BMS 536924,"IGF1R, IR",IGFR signaling,10390396,480.0,"'N', 'O', 'H', 'C', 'Cl'",10,0,2.7,0.0,98.2,856.0,4,7,5,34,1,1,0,1,1,C25H26ClN5O3,CC1=CC(=CC2=C1NC(=C3C(=CC=NC3=O)NCC(C4=CC(=CC=C4)Cl)O)N2)N5CCOCC5,"InChI=1S/C25H26ClN5O3/c1-15-11-18(31-7-9-34-10-8-31)13-20-23(15)30-24(29-20)22-19(5-6-27-25(22)33)28-14-21(32)16-3-2-4-17(26)12-16/h2-6,11-13,21,28-30,32H,7-10,14H2,1H3/b24-22+/t21-/m1/s1",UGQMURPIMYALPH-PZJQAWQVSA-N,0,0,1,0,1,0,1,0,0,0
1114,Cetuximab,"Erbitux, IMC-C225, C225, IMC-225, L01XC06",EGFR,EGFR signaling,85668777,273.37,"'C', 'N', 'H', 'O'",5,0,4.0,0.0,40.5,375.0,1,3,6,20,0,0,0,0,1,C17H23NO2,CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C,"InChI=1S/C17H23NO2/c1-13-17(2,3)14-9-6-7-10-15(14)18(13)12-8-4-5-11-16(19)20/h6-7,9-10H,1,4-5,8,11-12H2,2-3H3,(H,19,20)",LVVRHAVPVOVPGG-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1129,PF-4708671,"PF 4708671, PF4708671",S6K1,PI3K/MTOR signaling,51371303,390.4,"'C', 'F', 'N', 'H'",7,0,3.2,0.0,60.9,510.0,1,8,4,28,0,0,0,0,1,C19H21F3N6,CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F,"InChI=1S/C19H21F3N6/c1-2-13-10-23-12-24-18(13)28-7-5-27(6-8-28)11-17-25-15-4-3-14(19(20,21)22)9-16(15)26-17/h3-4,9-10,12H,2,5-8,11H2,1H3,(H,25,26)",FBLPQCAQRNSVHB-UHFFFAOYSA-N,0,0,1,0,0,0,0,0,1,0
1133,Serdemetan,JNJ-26854165,MDM2,p53 pathway,11609586,328.4,"'C', 'N', 'H'",10,0,4.6,0.0,52.7,387.0,3,3,6,25,0,0,0,0,1,C21H20N4,C1=CC=C2C(=C1)C(=CN2)CCNC3=CC=C(C=C3)NC4=CC=NC=C4,"InChI=1S/C21H20N4/c1-2-4-21-20(3-1)16(15-24-21)9-14-23-17-5-7-18(8-6-17)25-19-10-12-22-13-11-19/h1-8,10-13,15,23-24H,9,14H2,(H,22,25)",CEGSUKYESLWKJP-UHFFFAOYSA-N,0,0,1,0,0,0,0,0,0,0
1149,TW 37,"TW37, TW-37","BCL2, BCL-XL, MCL1",Apoptosis regulation,11455910,573.7,"'N', 'O', 'H', 'C', 'S'",15,0,7.8,0.0,132.0,963.0,4,6,8,41,0,0,0,0,1,C33H35NO6S,CC(C)C1=CC=CC=C1CC2=CC(=C(C(=C2O)O)O)C(=O)NC3=CC=C(C=C3)S(=O)(=O)C4=CC=CC=C4C(C)(C)C,"InChI=1S/C33H35NO6S/c1-20(2)25-11-7-6-10-21(25)18-22-19-26(30(36)31(37)29(22)35)32(38)34-23-14-16-24(17-15-23)41(39,40)28-13-9-8-12-27(28)33(3,4)5/h6-17,19-20,35-37H,18H2,1-5H3,(H,34,38)",PQAPVTKIEGUPRN-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
1161,ZG-10,-,JNK1,JNK and p38 signaling,57340680,493.6,"'C', 'N', 'H', 'O'",15,0,3.0,0.0,112.0,753.0,3,7,9,37,0,0,0,1,1,C28H27N7O2,CN(C)CC=CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=CC(=N3)C4=CN=CC=C4,"InChI=1S/C28H27N7O2/c1-35(2)17-5-9-26(36)31-22-12-10-20(11-13-22)27(37)32-23-7-3-8-24(18-23)33-28-30-16-14-25(34-28)21-6-4-15-29-19-21/h3-16,18-19H,17H2,1-2H3,(H,31,36)(H,32,37)(H,30,33,34)/b9-5+",VZEONOGFXYTZGT-WEVVVXLNSA-N,0,0,1,0,1,0,0,0,0,0
1164,XMD8-92,XMD 8-92,MAPK7,"Other, kinases",46843772,474.6,"'C', 'N', 'H', 'O'",10,0,3.5,0.0,94.1,719.0,2,8,5,35,0,0,0,0,1,C26H30N6O3,CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C,"InChI=1S/C26H30N6O3/c1-4-35-23-15-17(32-13-11-18(33)12-14-32)9-10-20(23)28-26-27-16-22-24(29-26)30(2)21-8-6-5-7-19(21)25(34)31(22)3/h5-10,15-16,18,33H,4,11-14H2,1-3H3,(H,27,28,29)",QAPAJIZPZGWAND-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1170,CCT-018159,"CCT018159, CCT 018159",HSP90,Protein stability and degradation,5327091,352.4,"'C', 'N', 'H', 'O'",8,0,2.7,0.0,79.8,747.0,3,6,2,26,0,0,0,1,1,C20H20N2O4,CCC1=CC(=C2C(=C(NN2)C)C3=CC4=C(C=C3)OCCO4)C(=O)C=C1O,"InChI=1S/C20H20N2O4/c1-3-12-8-14(16(24)10-15(12)23)20-19(11(2)21-22-20)13-4-5-17-18(9-13)26-7-6-25-17/h4-5,8-10,21-23H,3,6-7H2,1-2H3/b20-14-",BBTMGPQSLSYPHE-ZHZULCJRSA-N,0,0,1,0,1,0,0,0,0,0
1175,Rucaparib,"PF-01367338, AG-014699, AG-14447, AG-14699","PARP1, PARP2",Genome integrity,9931953,421.4,"'N', 'O', 'H', 'C', 'F', 'P'",9,0,,0.0,135.0,515.0,6,7,3,29,0,0,0,0,2,C19H21FN3O5P,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2.OP(=O)(O)O,"InChI=1S/C19H18FN3O.H3O4P/c1-21-10-11-2-4-12(5-3-11)18-14-6-7-22-19(24)15-8-13(20)9-16(23-18)17(14)15;1-5(2,3)4/h2-5,8-9,21,23H,6-7,10H2,1H3,(H,22,24);(H3,1,2,3,4)",FCCGJTKEKXUBFZ-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,1
1192,GSK269962A,GSK 269962A,"ROCK1, ROCK2",Cytoskeleton,16095342,570.6,"'C', 'N', 'H', 'O'",13,0,2.2,0.0,156.0,860.0,2,11,10,42,0,0,0,0,1,C29H30N8O5,CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6,"InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)",YOVNFNXUCOWYSG-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1194,SB-505124,"SB 505124, SB505124","ALK4, ALK5",RTK signaling,9858940,335.4,"'C', 'N', 'H', 'O'",8,0,4.3,0.0,60.0,466.0,1,4,3,25,0,0,0,0,1,C20H21N3O2,CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4,"InChI=1S/C20H21N3O2/c1-12-6-5-7-14(21-12)18-17(22-19(23-18)20(2,3)4)13-8-9-15-16(10-13)25-11-24-15/h5-10H,11H2,1-4H3,(H,22,23)",WGZOTBUYUFBEPZ-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1199,Tamoxifen,"Nolvadex, Soltamox, Zynoplex, ICI-46474, Kessar",ESR1,Hormone-related,2733526,371.5,"'C', 'N', 'H', 'O'",10,0,7.1,0.0,12.5,463.0,0,2,8,28,0,0,0,1,1,C26H29NO,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,"InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-",NKANXQFJJICGDU-QPLCGJKRSA-N,0,0,1,0,1,0,0,0,0,0
1218,JQ1,"JQ-1, (+)-JQ-1","BRD2, BRD3, BRD4, BRDT",Chromatin other,46907787,457.0,"'N', 'O', 'H', 'C', 'Cl', 'S'",9,0,4.9,0.0,97.6,706.0,0,6,5,31,1,1,0,0,1,C23H25ClN4O2S,CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C,"InChI=1S/C23H25ClN4O2S/c1-12-13(2)31-22-19(12)20(15-7-9-16(24)10-8-15)25-17(11-18(29)30-23(4,5)6)21-27-26-14(3)28(21)22/h7-10,17H,11H2,1-6H3/t17-/m0/s1",DNVXATUJJDPFDM-KRWDZBQOSA-N,0,0,1,0,1,0,1,1,0,0
1219,PFI-1,-,BRD4,Chromatin other,71271629,347.4,"'N', 'O', 'H', 'C', 'S'",9,0,1.2,0.0,96.1,562.0,2,5,4,24,0,0,0,0,1,C16H17N3O4S,CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O,"InChI=1S/C16H17N3O4S/c1-19-10-11-9-12(7-8-13(11)17-16(19)20)18-24(21,22)15-6-4-3-5-14(15)23-2/h3-9,18H,10H2,1-2H3,(H,17,20)",TXZPMHLMPKIUGK-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
1230,IOX2,"IOX-2, IOX 2, AK176060",EGLN1,Other,54685215,352.3,"'C', 'N', 'H', 'O'",10,0,2.6,0.0,107.0,609.0,3,5,5,26,0,0,0,0,1,C19H16N2O5,C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=C(C2=O)C(=O)NCC(=O)O)O,"InChI=1S/C19H16N2O5/c22-15(23)10-20-18(25)16-17(24)13-8-4-5-9-14(13)21(19(16)26)11-12-6-2-1-3-7-12/h1-9,24H,10-11H2,(H,20,25)(H,22,23)",CAOSCCRYLYQBES-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1236,UNC0638,"UNC-0638, UNC 0683",G9a and GLP methyltransferases,Chromatin histone methylation,46224516,509.7,"'C', 'N', 'H', 'O'",5,0,6.3,0.0,62.8,660.0,1,7,10,37,0,0,0,0,1,C30H47N5O2,CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)C5CCCCC5,"InChI=1S/C30H47N5O2/c1-22(2)35-17-12-24(13-18-35)31-30-25-20-27(36-3)28(37-19-9-16-34-14-7-8-15-34)21-26(25)32-29(33-30)23-10-5-4-6-11-23/h20-24H,4-19H2,1-3H3,(H,31,32,33)",QOECJCJVIMVJGX-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1239,YK-4-279,YK 4-279,RNA helicase A,Other,44632017,366.2,"'N', 'O', 'H', 'C', 'Cl'",8,0,3.1,0.0,75.6,509.0,2,4,4,24,1,0,1,0,1,C17H13Cl2NO4,COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O,"InChI=1S/C17H13Cl2NO4/c1-24-10-4-2-9(3-5-10)13(21)8-17(23)14-11(18)6-7-12(19)15(14)20-16(17)22/h2-7,23H,8H2,1H3,(H,20,22)",HLXSCTYHLQHQDJ-UHFFFAOYSA-N,0,0,1,0,1,0,1,0,0,0
1241,CHIR-99021,"CT 99021, CHIR99021, CHIR 99021","GSK3A, GSK3B",WNT signaling,9956119,465.3,"'C', 'N', 'H', 'Cl'",11,1,4.3,0.0,115.0,645.0,3,7,7,32,0,0,0,0,1,C22H18Cl2N8,CC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N,"InChI=1S/C22H18Cl2N8/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32)",AQGNHMOJWBZFQQ-UHFFFAOYSA-N,0,0,1,0,0,0,1,0,0,0
1242,(5Z)-7-Oxozeaenol,"5Z-7-Oxozeaenol, LL-Z1640-2",TAK1,"Other, kinases",9863776,362.4,"'C', 'H', 'O'",7,0,2.6,0.0,113.0,556.0,3,7,1,26,3,3,0,2,1,C19H22O7,CC1CC=CC(=O)C(C(CC=CC2=C(C(=CC(=C2)OC)O)C(=O)O1)O)O,"InChI=1S/C19H22O7/c1-11-5-3-7-14(20)18(23)15(21)8-4-6-12-9-13(25-2)10-16(22)17(12)19(24)26-11/h3-4,6-7,9-11,15,18,21-23H,5,8H2,1-2H3/b6-4+,7-3-/t11-,15-,18+/m0/s1",NEQZWEXWOFPKOT-BYRRXHGESA-N,0,0,0,0,1,0,0,0,0,0
1243,Piperlongumine,Piplartine,Induces reactive oxygen species,Other,637858,317.34,"'C', 'N', 'H', 'O'",7,0,2.1,0.0,65.1,473.0,0,5,5,23,0,0,0,1,1,C17H19NO5,COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCC=CC2=O,"InChI=1S/C17H19NO5/c1-21-13-10-12(11-14(22-2)17(13)23-3)7-8-16(20)18-9-5-4-6-15(18)19/h4,6-8,10-11H,5,9H2,1-3H3/b8-7+",VABYUUZNAVQNPG-BQYQJAHWSA-N,0,0,1,0,1,0,0,0,0,0
1248,Daporinad,"APO866,  FK866, FK866",NAMPT,Metabolism,6914657,391.5,"'C', 'N', 'H', 'O'",9,0,3.7,0.0,62.3,534.0,1,3,8,29,0,0,0,1,1,C24H29N3O2,C1CN(CCC1CCCCNC(=O)C=CC2=CN=CC=C2)C(=O)C3=CC=CC=C3,"InChI=1S/C24H29N3O2/c28-23(12-11-21-8-6-15-25-19-21)26-16-5-4-7-20-13-17-27(18-14-20)24(29)22-9-2-1-3-10-22/h1-3,6,8-12,15,19-20H,4-5,7,13-14,16-18H2,(H,26,28)/b12-11+",KPBNHDGDUADAGP-VAWYXSNFSA-N,0,0,1,0,1,0,0,0,0,0
1259,Talazoparib,"BMN-673, BMN 973","PARP1, PARP2",Genome integrity,44819241,380.4,"'N', 'O', 'H', 'C', 'F'",10,0,1.4,0.0,84.2,826.0,2,7,2,28,2,2,0,0,1,C19H14F2N6O,CN1C(=NC=N1)C2C(N=C3C=C(C=C4C3=C2NNC4=O)F)C5=CC=C(C=C5)F,"InChI=1S/C19H14F2N6O/c1-27-18(22-8-23-27)15-16(9-2-4-10(20)5-3-9)24-13-7-11(21)6-12-14(13)17(15)25-26-19(12)28/h2-8,15-16,25H,1H3,(H,26,28)/t15-,16-/m1/s1",IUEWAGVJRJORLA-HZPDHXFCSA-N,0,0,1,0,1,0,0,0,1,0
1262,UNC1215,UNC-1215,L3MBTL3,Chromatin other,57339144,529.7,"'C', 'N', 'H', 'O'",8,0,5.1,0.0,59.1,803.0,1,5,6,39,0,0,0,0,1,C32H43N5O2,C1CCN(C1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5CCCC5)NC6=CC=CC=C6,"InChI=1S/C32H43N5O2/c38-31(36-20-12-27(13-21-36)34-16-4-5-17-34)25-10-11-29(30(24-25)33-26-8-2-1-3-9-26)32(39)37-22-14-28(15-23-37)35-18-6-7-19-35/h1-3,8-11,24,27-28,33H,4-7,12-23H2",PQOOIERVZAXHBP-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1264,SGC0946,-,DOT1L,Chromatin histone methylation,56962337,618.6,"'Br', 'N', 'O', 'H', 'C'",8,0,3.0,0.0,151.0,825.0,5,8,10,40,4,4,0,0,1,C28H40BrN7O4,CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O,"InChI=1S/C28H40BrN7O4/c1-16(2)35(12-6-11-31-27(39)34-18-9-7-17(8-10-18)28(3,4)5)14-20-22(37)23(38)26(40-20)36-13-19(29)21-24(30)32-15-33-25(21)36/h7-10,13,15-16,20,22-23,26,37-38H,6,11-12,14H2,1-5H3,(H2,30,32,33)(H2,31,34,39)/t20-,22-,23-,26-/m1/s1",IQCKJUKAQJINMK-HUBRGWSESA-N,0,1,1,0,1,1,0,0,0,0
1268,XAV939,"NVP-XAV939, XAV-939, XAV 939","TNKS1, TNKS2",WNT signaling,2726824,312.31,"'N', 'O', 'H', 'C', 'S', 'F'",6,0,2.3,0.0,66.8,505.0,1,5,1,21,0,0,0,0,1,C14H11F3N2OS,C1CSCC2=C1NC(=NC2=O)C3=CC=C(C=C3)C(F)(F)F,"InChI=1S/C14H11F3N2OS/c15-14(16,17)9-3-1-8(2-4-9)12-18-11-5-6-21-7-10(11)13(20)19-12/h1-4H,5-7H2,(H,18,19,20)",KLGQSVMIPOVQAX-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,1,0
1371,PLX-4720,"PLX4720, PLX 4720",BRAF,ERK MAPK signaling,24180719,413.8,"'N', 'O', 'H', 'C', 'Cl', 'S', 'F'",10,0,3.3,0.0,100.0,648.0,2,7,6,27,0,0,0,0,1,C17H14ClF2N3O3S,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)Cl)F,"InChI=1S/C17H14ClF2N3O3S/c1-2-5-27(25,26)23-13-4-3-12(19)14(15(13)20)16(24)11-8-22-17-10(11)6-9(18)7-21-17/h3-4,6-8,23H,2,5H2,1H3,(H,21,22)",YZDJQTHVDDOVHR-UHFFFAOYSA-N,0,0,1,0,1,0,1,1,1,0
1372,Trametinib,"GSK1120212, Mekinist","MEK1, MEK2",ERK MAPK signaling,11707110,615.4,"'I', 'N', 'O', 'H', 'C', 'F'",12,0,3.4,0.0,102.0,1090.0,2,6,5,37,0,0,0,0,1,C26H23FIN5O4,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,"InChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)",LIRYPHYGHXZJBZ-UHFFFAOYSA-N,0,0,1,1,1,0,0,0,1,0
1373,Dabrafenib,"GSK2118436, Tafinlar",BRAF,ERK MAPK signaling,44462760,519.6,"'N', 'O', 'H', 'C', 'S', 'F'",13,0,4.8,0.0,148.0,817.0,2,11,6,35,0,0,0,0,1,C23H20F3N5O2S2,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,"InChI=1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29)",BFSMGDJOXZAERB-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,1,0
1375,Temozolomide,"Temodar, Temodal, M-39831, SCH 52365",DNA alkylating agent,DNA replication,5394,194.15,"'C', 'N', 'H', 'O'",5,0,-1.1,0.0,106.0,315.0,1,5,1,14,0,0,0,0,1,C6H6N6O2,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,"InChI=1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)",BPEGJWRSRHCHSN-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,0,0
1377,Afatinib,"BIBW2992, Tovok, Gilotrif","ERBB2, EGFR",EGFR signaling,10184653,485.9,"'N', 'O', 'H', 'C', 'Cl', 'F'",10,0,3.6,0.0,88.6,702.0,2,8,8,34,1,1,0,1,1,C24H25ClFN5O3,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,"InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1",ULXXDDBFHOBEHA-CWDCEQMOSA-N,0,0,1,0,1,0,1,0,1,0
1378,Bleomycin (50 uM),-,dsDNA break induction,DNA replication,5460769,1415.6,"'N', 'O', 'H', 'C', 'S'",17,0,-7.5,1.0,685.0,2580.0,20,31,36,96,19,19,0,0,1,C55H84N17O21S3+,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,"InChI=1S/C55H83N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81H,7-13,15-16,56H2,1-6H3,(H13-,57,58,59,60,61,62,63,65,66,69,70,71,72,76,82,83,84,85,86,87,88)/p+1/t21-,22+,23+,24-,25-,29-,30+,34-,35-,36-,37+,38+,39-,40-,41-,42-,43-,53+,54-/m0/s1",OYVAGSVQBOHSSS-UAPAGMARSA-O,0,0,1,0,1,0,0,1,0,0
1494,SN-38,"7-Ethyl-10-Hydroxy-Camptothecin, Irinotecan, Camptosar",TOP1,DNA replication,104842,392.4,"'C', 'N', 'H', 'O'",9,0,1.4,0.0,100.0,820.0,2,6,2,29,1,1,0,0,1,C22H20N2O5,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)O,"InChI=1S/C22H20N2O5/c1-3-12-13-7-11(25)5-6-17(13)23-19-14(12)9-24-18(19)8-16-15(20(24)26)10-29-21(27)22(16,28)4-2/h5-8,25,28H,3-4,9-10H2,1-2H3/t22-/m0/s1",FJHBVJOVLFPMQE-QFIPXVFZSA-N,0,0,1,0,1,0,0,0,0,0
1495,Olaparib,"AZD2281, KU0059436,  Lynparza","PARP1, PARP2",Genome integrity,23725625,434.5,"'N', 'O', 'H', 'C', 'F'",10,0,1.9,0.0,82.1,790.0,1,5,4,32,0,0,0,0,1,C24H23FN4O3,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,"InChI=1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30)",FDLYAMZZIXQODN-UHFFFAOYSA-N,0,0,1,0,1,0,0,0,1,0
1498,Selumetinib,"AZD6244, AZD-6244, ARRY-886","MEK1, MEK2",ERK MAPK signaling,10127622,457.7,"'Br', 'N', 'O', 'H', 'C', 'Cl', 'F'",8,0,3.6,0.0,88.4,523.0,3,6,6,27,0,0,0,0,1,C17H15BrClFN4O3,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,"InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)",CYOHGALHFOKKQC-UHFFFAOYSA-N,0,1,1,0,1,1,1,0,1,0
1502,Bicalutamide,"ICI-176334, Casodex, Cosudex, ICI 176334",AR,Hormone-related,2375,430.4,"'N', 'O', 'H', 'C', 'S', 'F'",9,1,2.3,0.0,116.0,750.0,2,9,5,29,1,0,1,0,1,C18H14F4N2O4S,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,"InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)",LKJPYSCBVHEWIU-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,1,0
1526,Refametinib,"RDEA119, BAY-86-9766, BAY 869766","MEK1, MEK2",ERK MAPK signaling,44182295,572.3,"'I', 'N', 'O', 'H', 'C', 'S', 'F'",8,0,2.8,0.0,116.0,711.0,4,10,9,31,1,1,0,0,1,C19H20F3IN2O5S,COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)CC(CO)O)NC3=C(C=C(C=C3)I)F)F)F,"InChI=1S/C19H20F3IN2O5S/c1-30-15-7-13(21)16(22)18(24-14-3-2-10(23)6-12(14)20)17(15)25-31(28,29)19(4-5-19)8-11(27)9-26/h2-3,6-7,11,24-27H,4-5,8-9H2,1H3/t11-/m0/s1",RDSACQWTXKSHJT-NSHDSACASA-N,0,0,1,1,1,0,0,1,1,0
1527,Pictilisib,"GDC-0941, GDC0941, RG-7621",PI3K (class 1),PI3K/MTOR signaling,17755052,513.6,"'N', 'O', 'H', 'C', 'S'",10,0,1.6,0.0,144.0,832.0,1,10,5,35,0,0,0,0,1,C23H27N7O3S2,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,"InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27)",LHNIIDJUOCFXAP-UHFFFAOYSA-N,0,0,1,0,1,0,0,1,0,0
1529,Pevonedistat,"MLN4924, MLN 4924, MLN-4924",NAE,Other,16720766,443.5,"'N', 'O', 'H', 'C', 'S'",9,0,1.7,0.0,141.0,734.0,3,8,6,31,4,4,0,0,1,C21H25N5O4S,C1CC2=CC=CC=C2C1NC3=C4C=CN(C4=NC=N3)C5CC(C(C5)O)COS(=O)(=O)N,"InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18-,19-/m0/s1",MPUQHZXIXSTTDU-QXGSTGNESA-N,0,0,1,0,1,0,0,1,0,0
